Myron Levine

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Vidal Roberto M; Valenzuela Patricio; Baker Kelly; Lagos Rosanna; Esparza Mario; Livio Sofie; Farfán Mauricio; Nataro James P; Levine Myron M; Prado Valeria
Characterization of the most prevalent colonization factor antigens present in Chilean clinical enterotoxigenic Escherichia coli strains using a new multiplex polymerase chain reaction.
Lagos Rosanna; Muñoz Alma; Espinoza Aníbal; Dowes Angela; Ruttimann Ricardo; Colindres Rómulo; Levine Myron M
[Direct medical costs of invasive pneumococcal disease and radiologically-diagnosed pneumonia among Chilean children]
Galen James E; Pasetti Marcela F; Tennant Sharon; Ruiz-Olvera Patricia; Sztein Marcelo B; Levine Myron M
Salmonella enterica serovar Typhi live vector vaccines finally come of age.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Myron Levine (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Vidal Roberto M; Valenzuela Patricio; Baker Kelly; Lagos Rosanna; Esparza Mario; Livio Sofie; Farfán Mauricio; Nataro James P; Levine Myron M; Prado Valeria
Characterization of the most prevalent colonization factor antigens present in Chilean clinical enterotoxigenic Escherichia coli strains using a new multiplex polymerase chain reaction.
Diagnostic microbiology and infectious disease 2009;65(3):217-23.
2009: Lagos Rosanna; Muñoz Alma; Espinoza Aníbal; Dowes Angela; Ruttimann Ricardo; Colindres Rómulo; Levine Myron M
[Direct medical costs of invasive pneumococcal disease and radiologically-diagnosed pneumonia among Chilean children]
Revista panamericana de salud pública = Pan American journal of public health 2009;26(2):101-11.
2009: Galen James E; Pasetti Marcela F; Tennant Sharon; Ruiz-Olvera Patricia; Sztein Marcelo B; Levine Myron M
Salmonella enterica serovar Typhi live vector vaccines finally come of age.
Immunology and cell biology 2009;87(5):400-12.
2009: Sow Samba O; Tapia Milagritos D; Diallo Souleymane; Keita Mamadou Marouf; Sylla Mariam; Onwuchekwa Uma; Pasetti Marcela F; Kotloff Karen L; Levine Myron M
Haemophilus influenzae Type B conjugate vaccine introduction in Mali: impact on disease burden and serologic correlate of protection.
The American journal of tropical medicine and hygiene 2009;80(6):1033-8.
2009: Levine Myron M; Robins-Browne Roy
Vaccines, global health and social equity.
Immunology and cell biology 2009;87(4):274-8.
2009: Lagos Rosanna; Munoz Alma; Levine Myron M; Watson Wendy; Chang Ih; Paradiso Peter
Immunology of combining CRM(197) conjugates for Streptococcus pneumoniae, Neisseria meningitis and Haemophilus influenzae in Chilean infants.
Vaccine 2009;27(17):2299-305.
2009: Santiago Araceli E; Cole Leah E; Franco Augusto; Vogel Stefanie N; Levine Myron M; Barry Eileen M
Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes.
Vaccine 2009;27(18):2426-36.
2009: Pasetti Marcela F; Ramirez Karina; Resendiz-Albor Aldo; Ulmer Jeffrey; Barry Eileen M; Levine Myron M
Sindbis virus-based measles DNA vaccines protect cotton rats against respiratory measles: relevance of antibodies, mucosal and systemic antibody-secreting cells, memory B cells, and Th1-type cytokines as correlates of immunity.
Journal of virology 2009;83(6):2789-94.
2009: Sigaúque Betuel; Roca Anna; Mandomando Inácio; Morais Luís; Quintó Llorenç; Sacarlal Jahit; Macete Eusébio; Nhamposa Tacilta; Machevo Sónia; Aide Pedro; Bassat Quique; Bardají Azucena; Nhalungo Delino; Soriano-Gabarró Montse; Flannery Brendan; Menendez Clara; Levine Myron M; Alonso Pedro L
Community-acquired bacteremia among children admitted to a rural hospital in Mozambique.
The Pediatric infectious disease journal 2009;28(2):108-13.
2009: Galen James E; Chinchilla Magaly; Pasetti Marcela F; Wang Jin Yuan; Zhao Licheng; Arciniega-Martinez Ivonne; Silverman David J; Levine Myron M
Mucosal immunization with attenuated Salmonella enterica serovar Typhi expressing protective antigen of anthrax toxin (PA83) primes monkeys for accelerated serum antibody responses to parenteral PA83 vaccine.
The Journal of infectious diseases 2009;199(3):326-35.
2009: Simon J K; Wahid R; Maciel M; Picking W L; Kotloff K L; Levine M M; Sztein M B
Antigen-specific B memory cell responses to lipopolysaccharide (LPS) and invasion plasmid antigen (Ipa) B elicited in volunteers vaccinated with live-attenuated Shigella flexneri 2a vaccine candidates.
Vaccine 2009;27(4):565-72.
2008: Lagos Rosanna; Muñoz Alma; San Martin Oriana; Maldonado Aurora; Hormazabal Juan Carlos; Blackwelder William C; Levine Myron M
Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007.
The Journal of infectious diseases 2008;198(12):1809-17.
2008: Mandomando Inácio M; Naniche Denise; Pasetti Marcela F; Vallès Xavier; Cuberos Lilian; Nhacolo Ariel; Kotloff Karen L; Martins Helder; Levine Myron M; Alonso Pedro
Measles-specific neutralizing antibodies in rural Mozambique: seroprevalence and presence in breast milk.
The American journal of tropical medicine and hygiene 2008;79(5):787-92.
2008: Fang Chee-Mun; Wang Jin Yuan; Chinchilla Magaly; Levine Myron M; Blackwelder William C; Galen James E
Use of mchI encoding immunity to the antimicrobial peptide microcin H47 as a plasmid selection marker in attenuated bacterial live vectors.
Infection and immunity 2008;76(10):4422-30.
2008: Wahid R; Salerno-Gonçalves R; Tacket C O; Levine M M; Sztein M B
Generation of specific effector and memory T cells with gut- and secondary lymphoid tissue- homing potential by oral attenuated CVD 909 typhoid vaccine in humans.
Mucosal immunology 2008;1(5):389-98.
2008: Roca Anna; Quintó Llorenç; Abacassamo Fatima; Morais Luis; Vallès Xavi; Espasa Mateu; Sigaúque Betuel; Sacarlal Jahit; Macete Eusebio; Nhacolo Ariel; Mandomando Inacio; Levine Myron M; Alonso Pedro L
Invasive Haemophilus influenzae disease in children less than 5 years of age in Manhiça, a rural area of southern Mozambique.
Tropical medicine & international health : TM & IH 2008;13(6):818-26.
2008: Ramirez Karina; Barry Eileen M; Ulmer Jeffrey; Stout Richard; Szabo James; Manetz Scott; Levine Myron M; Pasetti Marcela F
Preclinical safety and biodistribution of Sindbis virus measles DNA vaccines administered as a single dose or followed by live attenuated measles vaccine in a heterologous prime-boost regimen.
Human gene therapy 2008;19(5):522-31.
2008: Levy Haim; Diallo Souleymane; Tennant Sharon M; Livio Sofie; Sow Samba O; Tapia Milagritos; Fields Patricia I; Mikoleit Matthew; Tamboura Boubou; Kotloff Karen L; Lagos Rosanna; Nataro James P; Galen James E; Levine Myron M
PCR method to identify Salmonella enterica serovars Typhi, Paratyphi A, and Paratyphi B among Salmonella Isolates from the blood of patients with clinical enteric fever.
Journal of clinical microbiology 2008;46(5):1861-6.
2008: Petri William A; Miller Mark; Binder Henry J; Levine Myron M; Dillingham Rebecca; Guerrant Richard L
Enteric infections, diarrhea, and their impact on function and development.
The Journal of clinical investigation 2008;118(4):1277-90.
2008: Cross Alan S; Chen Wilbur H; Levine Myron M
A case for immunization against nosocomial infections.
Journal of leukocyte biology 2008;83(3):483-8.
2008: Sigaúque B; Roca A; Sanz S; Oliveiras I; Martínez M; Mandomando I; Vallès X; Espasa M; Abacassamo F; Sacarlal J; Macete E; Nhacolo A; Aponte J; Levine M M; Alonso P L
Acute bacterial meningitis among children, in Manhiça, a rural area in Southern Mozambique.
Acta tropica 2008;105(1):21-7.
2007: Pasetti M F; Resendiz-Albor A; Ramirez K; Stout R; Papania M; Adams R J; Polack F P; Ward B J; Burt D; Chabot S; Ulmer J; Barry E M; Levine M M
Heterologous prime-boost strategy to immunize very young infants against measles: pre-clinical studies in rhesus macaques.
Clinical pharmacology and therapeutics 2007;82(6):672-85.
2007: Mandomando Inácio; Sigaúque Betuel; Vallès Xavier; Espasa Mateu; Sanz Sergi; Sacarlal Jahit; Macete Eusébio; Abacassamo Fátima; Ruiz Joaquim; Gascon Joaquim; Kotloff Karen L; Levine Myron M; Alonso Pedro L
Epidemiology and clinical presentation of shigellosis in children less than five years of age in rural Mozambique.
The Pediatric infectious disease journal 2007;26(11):1059-61.
2007: Kotloff Karen L; Simon Jakub K; Pasetti Marcela F; Sztein Marcelo B; Wooden Stacey L; Livio Sofie; Nataro James P; Blackwelder William C; Barry Eileen M; Picking Wendy; Levine Myron M
Safety and immunogenicity of CVD 1208S, a live, oral DeltaguaBA Deltasen Deltaset Shigella flexneri 2a vaccine grown on animal-free media.
Human vaccines 2007;3(6):268-75.
2007: Chinchilla Magaly; Pasetti Marcela F; Medina-Moreno Sandra; Wang Jin Yuan; Gomez-Duarte Oscar G; Stout Rick; Levine Myron M; Galen James E
Enhanced immunity to Plasmodium falciparum circumsporozoite protein (PfCSP) by using Salmonella enterica serovar Typhi expressing PfCSP and a PfCSP-encoding DNA vaccine in a heterologous prime-boost strategy.
Infection and immunity 2007;75(8):3769-79.
2007: Levine Myron M; Ferreccio Catterine; Black Robert E; Lagos Rosanna; San Martin Oriana; Blackwelder William C
Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica Serovar Paratyphi B.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45 Suppl 1():S24-8.
2007: Tacket Carol O; Levine Myron M
CVD 908, CVD 908-htrA, and CVD 909 live oral typhoid vaccines: a logical progression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45 Suppl 1():S20-3.
2007: Levine Myron M; Kotloff Karen L; Barry Eileen M; Pasetti Marcela F; Sztein Marcelo B
Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road.
Nature reviews. Microbiology 2007;5(7):540-53.
2007: Simon Jakub K; Pasetti Marcela F; Viret Jean-François; Mischler Robert; Muñoz Alma; Lagos Rosanna; Levine Myron M; Campbell James D
A clinical study to assess the safety and immunogenicity of attenuated measles vaccine administered intranasally to healthy adults.
Human vaccines 2007;3(2):54-8.
2007: Wahid Rezwanul; Salerno-Gonçalves Rosangela; Tacket Carol O; Levine Myron M; Sztein Marcelo B
Cell-mediated immune responses in humans after immunization with one or two doses of oral live attenuated typhoid vaccine CVD 909.
Vaccine 2007;25(8):1416-25.
2007: Levine Myron
University of Maryland, Baltimore's participation in global health.
Maryland medicine : MM : a publication of MEDCHI, the Maryland State Medical Society 2007;8(3):27-9.
2006: Tapia Milagritos D; Pasetti Marcela F; Cuberos Lilian; Sow Samba O; Doumbia Mama N; Bagayogo Modibo; Kotloff Karen L; Levine Myron M
Measurement of tetanus antitoxin in oral fluid: a tool to conduct serosurveys.
The Pediatric infectious disease journal 2006;25(9):819-25.
2006: Lagos Rosanna M; Muñoz Alma E; Levine Myron M
Prevalence of pneumococcal bacteremia among children <36 months of age presenting with moderate fever to pediatric emergency rooms of the Metropolitan Region (Santiago), Chile.
Human vaccines 2006;2(3):129-33.
2006: Capozzo Alejandra V E; Ramírez Karina; Polo John M; Ulmer Jeffrey; Barry Eileen M; Levine Myron M; Pasetti Marcela F
Neonatal immunization with a Sindbis virus-DNA measles vaccine induces adult-like neutralizing antibodies and cell-mediated immunity in the presence of maternal antibodies.
Journal of immunology (Baltimore, Md. : 1950) 2006;176(9):5671-81.
2006: Levine Myron M
Enteric infections and the vaccines to counter them: future directions.
Vaccine 2006;24(18):3865-73.
2006: Barry Eileen M; Wang Jin; Wu Tao; Davis Tamar; Levine Myron M
Immunogenicity of multivalent Shigella-ETEC candidate vaccine strains in a guinea pig model.
Vaccine 2006;24(18):3727-34.
2006: Vallès Xavier; Flannery Brendan; Roca Anna; Mandomando Inacio; Sigaúque Betuel; Sanz Sergi; Schuchat Anne; Levine Myron; Soriano-Gabarró Montserrat; Alonso Pedro
Serotype distribution and antibiotic susceptibility of invasive and nasopharyngeal isolates of Streptococcus pneumoniae among children in rural Mozambique.
Tropical medicine & international health : TM & IH 2006;11(3):358-66.
2006: Levine M M
Mass vaccination to control epidemic and endemic typhoid fever.
Current topics in microbiology and immunology 2006;304():231-46.
2005: Vidal Maricel; Kruger Eileen; Durán Claudia; Lagos Rosanna; Levine Myron; Prado Valeria; Toro Cecilia; Vidal Roberto
Single multiplex PCR assay to identify simultaneously the six categories of diarrheagenic Escherichia coli associated with enteric infections.
Journal of clinical microbiology 2005;43(10):5362-5.
2005: Song Man Ki; Vindurampulle Christofer J; Capozzo Alejandra V E; Ulmer Jeffrey; Polo John M; Pasetti Marcela F; Barry Eileen M; Levine Myron M
Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Journal of virology 2005;79(15):9854-61.
2005: Tapia Milagritos D; Sow Samba O; Medina-Moreno Sandra; Lim Yu; Pasetti Marcela F; Kotloff Karen; Levine Myron M
A serosurvey to identify the window of vulnerability to wild-type measles among infants in rural Mali.
The American journal of tropical medicine and hygiene 2005;73(1):26-31.
2005: Fullá Noelia; Prado Valeria; Durán Claudia; Lagos Rosanna; Levine Myron M
Surveillance for antimicrobial resistance profiles among Shigella species isolated from a semirural community in the northern administrative area of santiago, chile.
The American journal of tropical medicine and hygiene 2005;72(6):851-4.
2005: Sow Samba O; Diallo Souleymane; Campbell James D; Tapia Milagritos D; Keita Tatiana; Keita Mamadou Marouf; Murray Patrick; Kotloff Karen L; Levine Myron M
Burden of invasive disease caused by Haemophilus influenzae type b in Bamako, Mali: impetus for routine infant immunization with conjugate vaccine.
The Pediatric infectious disease journal 2005;24(6):533-7.
2005: Lagos Rosanna; Hoffenbach Agnès; Scemama Michel; Dupuy Martin; Schodel Florian; Hessel Luc; Levine Myron
Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular-pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age.
Human vaccines 2005;1(3):112-7.
2005: Levine Myron M; Lepage Philippe
Prevention of typhoid fever.
Advances in experimental medicine and biology 2005;568():161-73.
2004: Galen James E; Zhao Licheng; Chinchilla Magaly; Wang Jin Yuan; Pasetti Marcela F; Green Jeffrey; Levine Myron M
Adaptation of the endogenous Salmonella enterica serovar Typhi clyA-encoded hemolysin for antigen export enhances the immunogenicity of anthrax protective antigen domain 4 expressed by the attenuated live-vector vaccine strain CVD 908-htrA.
Infection and immunity 2004;72(12):7096-106.
2004: Kotloff Karen L; Pasetti Marcela F; Barry Eileen M; Nataro James P; Wasserman Steven S; Sztein Marcelo B; Picking William D; Levine Myron M
Deletion in the Shigella enterotoxin genes further attenuates Shigella flexneri 2a bearing guanine auxotrophy in a phase 1 trial of CVD 1204 and CVD 1208.
The Journal of infectious diseases 2004;190(10):1745-54.
2004: Vindurampulle Christofer J; Cuberos Lilian F; Barry Eileen M; Pasetti Marcela F; Levine Myron M
Recombinant Salmonella enterica serovar Typhi in a prime-boost strategy.
Vaccine 2004;22(27-28):3744-50.
2004: Capozzo Alejandra V E; Cuberos Lilian; Levine Myron M; Pasetti Marcela F
Mucosally delivered Salmonella live vector vaccines elicit potent immune responses against a foreign antigen in neonatal mice born to naive and immune mothers.
Infection and immunity 2004;72(8):4637-46.
2004: Tacket Carol O; Pasetti Marcela F; Sztein Marcelo B; Livio Sofie; Levine Myron M
Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide.
The Journal of infectious diseases 2004;190(3):565-70.
2004: Campbell James D; Kotloff Karen L; Sow Samba O; Tapia Milagritos; Keita Mamadou Marouf; Keita Tatiana; Diallo Souleymane; Hormazabal Juan Carlos; Murray Patrick; Levine Myron M
Invasive pneumococcal infections among hospitalized children in Bamako, Mali.
The Pediatric infectious disease journal 2004;23(7):642-9.
2004: Campbell James D; Sow Samba O; Levine Myron M; Kotloff Karen L
The causes of hospital admission and death among children in Bamako, Mali.
Journal of tropical pediatrics 2004;50(3):158-63.
2004: Wyborn Neil R; Clark Angela; Roberts Ruth E; Jamieson Stuart J; Tzokov Svetomir; Bullough Per A; Stillman Timothy J; Artymiuk Peter J; Galen James E; Zhao Licheng; Levine Myron M; Green Jeffrey
Properties of haemolysin E (HlyE) from a pathogenic Escherichia coli avian isolate and studies of HlyE export.
Microbiology (Reading, England) 2004;150(Pt 5):1495-505.
2004: Levine Myron M; Sztein Marcelo B
Vaccine development strategies for improving immunization: the role of modern immunology.
Nature immunology 2004;5(5):460-4.
2004: Vidal Roberto; Vidal Maricel; Lagos Rossana; Levine Myron; Prado Valeria
Multiplex PCR for diagnosis of enteric infections associated with diarrheagenic Escherichia coli.
Journal of clinical microbiology 2004;42(4):1787-9.
2004: Mallet Eric; Belohradsky Bernd H; Lagos Rosanna; Gothefors Leif; Camier Patrice; Carrière Jean-Pierre; Kanra Güler; Hoffenbach Agnès; Langue Jacques; Undreiner François; Roussel François; Reinert Philippe; Flodmark Carl-Erik; Stojanov Silvia; Liese Johannes; Levine Myron M; Muñoz Alma; Schödel Florian; Hessel Luc;
A liquid hexavalent combined vaccine against diphtheria, tetanus, pertussis, poliomyelitis, Haemophilus influenzae type B and hepatitis B: review of immunogenicity and safety.
Vaccine 2004;22(11-12):1343-57.
2004: Li Yanwen; Sun Yao-hui; Ison Cathy; Levine Myron M; Tang Christoph M
Vaccination with attenuated Neisseria meningitidis strains protects against challenge with live Meningococci.
Infection and immunity 2004;72(1):345-51.
2003: Levine Myron M
Use of vaccines for the prevention of typhoid fever.
Indian pediatrics 2003;40(11):1029-34.
2003: Lagos Rosanna; Munoz Alma; Dumas Rafaele; Pichon Sylvie; Zambrano Betzana; Levine Myron; Vidor Emmanuel
Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
Vaccine 2003;21(25-26):3730-3.
2003: Pasetti Marcela F; Barry Eileen M; Losonsky Genevieve; Singh Mahender; Medina-Moreno Sandra M; Polo John M; Ulmer Jeffrey; Robinson Harriet; Sztein Marcelo B; Levine Myron M
Attenuated Salmonella enterica serovar Typhi and Shigella flexneri 2a strains mucosally deliver DNA vaccines encoding measles virus hemagglutinin, inducing specific immune responses and protection in cotton rats.
Journal of virology 2003;77(9):5209-17.
2003: Altboum Zeev; Levine Myron M; Galen James E; Barry Eileen M
Genetic characterization and immunogenicity of coli surface antigen 4 from enterotoxigenic Escherichia coli when it is expressed in a Shigella live-vector strain.
Infection and immunity 2003;71(3):1352-60.
2003: Salerno-Gonçalves Rosângela; Wyant Timothy L; Pasetti Marcela F; Fernandez-Viña Marcelo; Tacket Carol O; Levine Myron M; Sztein Marcelo B
Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA.
Journal of immunology (Baltimore, Md. : 1950) 2003;170(5):2734-41.
2003: Pasetti Marcela F; Levine Myron M; Sztein Marcelo B
Animal models paving the way for clinical trials of attenuated Salmonella enterica serovar Typhi live oral vaccines and live vectors.
Vaccine 2003;21(5-6):401-18.
2003: Barry Eileen M; Altboum Zeev; Losonsky Genevieve; Levine Myron M
Immune responses elicited against multiple enterotoxigenic Escherichia coli fimbriae and mutant LT expressed in attenuated Shigella vaccine strains.
Vaccine 2003;21(5-6):333-40.
2003: Levine Myron M
Can needle-free administration of vaccines become the norm in global immunization?
Nature medicine 2003;9(1):99-103.
2002: Lagos Rosanna; Muñoz Alma; Valenzuela Maria Teresa; Heitmann Ingrid; Levine Myron M
Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile.
The Pediatric infectious disease journal 2002;21(12):1115-23.
2002: Campbell James D; Lagos Rosanna; Levine Myron M; Losonsky Genevieve A
Standard and alternative regimens of Haemophilus influenzae type b conjugate vaccine (polyribosylribitol phosphate-tetanus toxoid conjugate vaccine) elicit comparable antibody avidities in infants.
The Pediatric infectious disease journal 2002;21(9):822-6.
2002: Ruiz-Pérez Fernando; León-Kempis Rocío; Santiago-Machuca Araceli; Ortega-Pierres Guadalupe; Barry Eileen; Levine Myron; González-Bonilla César
Expression of the Plasmodium falciparum immunodominant epitope (NANP)(4) on the surface of Salmonella enterica using the autotransporter MisL.
Infection and immunity 2002;70(7):3611-20.
2002: Kidgell Claire; Pickard Derek; Wain John; James Keith; Diem Nga L T; Diep To Song; Levine Myron M; O'Gaora Peadar; Prentice Michael B; Parkhill Julian; Day Nicholas; Farrar Jeremy; Dougan Gordon
Characterisation and distribution of a cryptic Salmonella typhi plasmid pHCM2.
Plasmid 2002;47(3):159-71.
2002: Kotloff Karen L; Taylor David N; Sztein Marcelo B; Wasserman Steven S; Losonsky Genevieve A; Nataro James P; Venkatesan Malabi; Hartman Antoinette; Picking William D; Katz David E; Campbell James D; Levine Myron M; Hale Thomas L
Phase I evaluation of delta virG Shigella sonnei live, attenuated, oral vaccine strain WRSS1 in healthy adults.
Infection and immunity 2002;70(4):2016-21.
2002: Stephens Ina; Levine Myron M
Management of typhoid fever in children.
The Pediatric infectious disease journal 2002;21(2):157-8.
2002: Levine Myron M; Campbell James D; Kotloff Karen L
Overview of vaccines and immunisation.
British medical bulletin 2002;62():1-13.
2001: Levine M M; Tacket C O; Sztein M B
Host-Salmonella interaction: human trials.
Microbes and infection / Institut Pasteur 2001;3(14-15):1271-9.
2001: Galen J E; Levine M M
Can a 'flawless' live vector vaccine strain be engineered?
Trends in microbiology 2001;9(8):372-6.
2001: Wang J Y; Pasetti M F; Noriega F R; Anderson R J; Wasserman S S; Galen J E; Sztein M B; Levine M M
Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated DeltaguaBA Salmonella enterica serovar Typhi strain CVD 915.
Infection and immunity 2001;69(8):4734-41.
2001: Jean S; LeVan K M; Song B; Levine M; Knipe D M
Herpes simplex virus 1 ICP27 is required for transcription of two viral late (gamma 2) genes in infected cells.
Virology 2001;283(2):273-84.
2001: Altboum Z; Barry E M; Losonsky G; Galen J E; Levine M M
Attenuated Shigella flexneri 2a Delta guaBA strain CVD 1204 expressing enterotoxigenic Escherichia coli (ETEC) CS2 and CS3 fimbriae as a live mucosal vaccine against Shigella and ETEC infection.
Infection and immunity 2001;69(5):3150-8.
2001: Cooper P J; Chico M; Sandoval C; Espinel I; Guevara A; Levine M M; Griffin G E; Nutman T B
Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.
Infection and immunity 2001;69(3):1574-80.
2001: Orr N; Galen J E; Levine M M
Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.
Vaccine 2001;19(13-14):1694-700.
2001: Gómez-Duarte O G; Pasetti M F; Santiago A; Sztein M B; Hoffman S L; Levine M M
Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains.
Infection and immunity 2001;69(2):1192-8.
2000: Plaisance K I; Kudaravalli S; Wasserman S S; Levine M M; Mackowiak P A
Effect of antipyretic therapy on the duration of illness in experimental influenza A, Shigella sonnei, and Rickettsia rickettsii infections.
Pharmacotherapy 2000;20(12):1417-22.
2000: Tacket C O; Galen J; Sztein M B; Losonsky G; Wyant T L; Nataro J; Wasserman S S; Edelman R; Chatfield S; Dougan G; Levine M M
Safety and immune responses to attenuated Salmonella enterica serovar typhi oral live vector vaccines expressing tetanus toxin fragment C.
Clinical immunology (Orlando, Fla.) 2000;97(2):146-53.
2000: Levine M M
Immunization against bacterial diseases of the intestine.
Journal of pediatric gastroenterology and nutrition 2000;31(4):336-55.
2000: Cooper P J; Chico M E; Losonsky G; Sandoval C; Espinel I; Sridhara R; Aguilar M; Guevara A; Guderian R H; Levine M M; Griffin G E; Nutman T B
Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR.
The Journal of infectious diseases 2000;182(4):1199-206.
2000: Wu S; Beier M; Sztein M B; Galen J; Pickett T; Holder A A; Gómez-Duarte O G; Levine M M
Construction and immunogenicity in mice of attenuated Salmonella typhi expressing Plasmodium falciparum merozoite surface protein 1 (MSP-1) fused to tetanus toxin fragment C.
Journal of biotechnology 2000;83(1-2):125-35.
2000: Koprowski H; Levine M M; Anderson R J; Losonsky G; Pizza M; Barry E M
Attenuated Shigella flexneri 2a vaccine strain CVD 1204 expressing colonization factor antigen I and mutant heat-labile enterotoxin of enterotoxigenic Escherichia coli.
Infection and immunity 2000;68(9):4884-92.
2000: Wang J Y; Noriega F R; Galen J E; Barry E; Levine M M
Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909.
Infection and immunity 2000;68(8):4647-52.
2000: Pasetti M F; Pickett T E; Levine M M; Sztein M B
A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model.
Vaccine 2000;18(28):3208-13.
2000: Tacket C O; Mason H S; Losonsky G; Estes M K; Levine M M; Arntzen C J
Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes.
The Journal of infectious diseases 2000;182(1):302-5.
2000: Tacket C O; Sztein M B; Losonsky G; Abe A; Finlay B B; McNamara B P; Fantry G T; James S P; Nataro J P; Levine M M; Donnenberg M S
Role of EspB in experimental human enteropathogenic Escherichia coli infection.
Infection and immunity 2000;68(6):3689-95.
2000: Richie E E; Punjabi N H; Sidharta Y Y; Peetosutan K K; Sukandar M M; Wasserman S S; Lesmana M M; Wangsasaputra F F; Pandam S S; Levine M M; O'Hanley P P; Cryz S J; Simanjuntak C H
Efficacy trial of single-dose live oral cholera vaccine CVD 103-HgR in North Jakarta, Indonesia, a cholera-endemic area.
Vaccine 2000;18(22):2399-410.
2000: Anderson R J; Pasetti M F; Sztein M B; Levine M M; Noriega F R
DeltaguaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin.
Vaccine 2000;18(21):2193-202.
2000: Tacket C O; Sztein M B; Wasserman S S; Losonsky G; Kotloff K L; Wyant T L; Nataro J P; Edelman R; Perry J; Bedford P; Brown D; Chatfield S; Dougan G; Levine M M
Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers.
Infection and immunity 2000;68(3):1196-201.
2000: Kotloff K L; Noriega F R; Samandari T; Sztein M B; Losonsky G A; Nataro J P; Picking W D; Barry E M; Levine M M
Shigella flexneri 2a strain CVD 1207, with specific deletions in virG, sen, set, and guaBA, is highly attenuated in humans.
Infection and immunity 2000;68(3):1034-9.
2000: Samandari T; Kotloff K L; Losonsky G A; Picking W D; Sansonetti P J; Levine M M; Sztein M B
Production of IFN-gamma and IL-10 to Shigella invasins by mononuclear cells from volunteers orally inoculated with a Shiga toxin-deleted Shigella dysenteriae type 1 strain.
Journal of immunology (Baltimore, Md. : 1950) 2000;164(4):2221-32.
2000: Pickett T E; Pasetti M F; Galen J E; Sztein M B; Levine M M
In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar Typhi strains as live mucosal vaccines and as live vectors.
Infection and immunity 2000;68(1):205-13.
1999: Levine O S; Lagos R; Muñoz A; Villaroel J; Alvarez A M; Abrego P; Levine M M
Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b.
The Pediatric infectious disease journal 1999;18(12):1060-4.
1999: Galen J E; Nair J; Wang J Y; Wasserman S S; Tanner M K; Sztein M B; Levine M M
Optimization of plasmid maintenance in the attenuated live vector vaccine strain Salmonella typhi CVD 908-htrA.
Infection and immunity 1999;67(12):6424-33.
1999: Tacket C O; Cohen M B; Wasserman S S; Losonsky G; Livio S; Kotloff K; Edelman R; Kaper J B; Cryz S J; Giannella R A; Schiff G; Levine M M
Randomized, double-blind, placebo-controlled, multicentered trial of the efficacy of a single dose of live oral cholera vaccine CVD 103-HgR in preventing cholera following challenge with Vibrio cholerae O1 El tor inaba three months after vaccination.
Infection and immunity 1999;67(12):6341-5.
1999: Taylor D N; Levine M M; Kuppens L; Ivanoff B
Why are typhoid vaccines not recommended for epidemic typhoid fever?
The Journal of infectious diseases 1999;180(6):2089-90.
1999: Lagos R; Fasano A; Wasserman S S; Prado V; San Martin O; Abrego P; Losonsky G A; Alegria S; Levine M M
Effect of small bowel bacterial overgrowth on the immunogenicity of single-dose live oral cholera vaccine CVD 103-HgR.
The Journal of infectious diseases 1999;180(5):1709-12.
1999: Levine M M; Ferreccio C; Abrego P; Martin O S; Ortiz E; Cryz S
Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine.
Vaccine 1999;17 Suppl 2():S22-7.
1999: Peter G; des Vignes-Kendrick M; Eickhoff T C; Fine A; Galvin V; Levine M M; Maldonado Y A; Marcuse E K; Monath T P; Osborn J E; Plotkin S; Poland G A; Quinlisk M P; Smith D R; Sokol M; Soland D B; Whitley-Williams P N; Williamson D E; Breiman R F
Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee.
Pediatrics 1999;104(4 Pt 1):942-50.
1999: Lagos R; Avendaño L F; Levine M M
[Systematic surveillance of influenza, syncytial respiratory, parainfluenza and adenovirus in children with acute respiratory infections]
Revista médica de Chile 1999;127(9):1063-72.
1999: Orr N; Galen J E; Levine M M
Expression and immunogenicity of a mutant diphtheria toxin molecule, CRM(197), and its fragments in Salmonella typhi vaccine strain CVD 908-htrA.
Infection and immunity 1999;67(8):4290-4.
1999: Lagos R; San Martin O; Wasserman S S; Prado V; Losonsky G A; Bustamante C; Levine M M
Palatability, reactogenicity and immunogenicity of engineered live oral cholera vaccine CVD 103-HgR in Chilean infants and toddlers.
The Pediatric infectious disease journal 1999;18(7):624-30.
1999: Pasetti M F; Anderson R J; Noriega F R; Levine M M; Sztein M B
Attenuated deltaguaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses.
Clinical immunology (Orlando, Fla.) 1999;92(1):76-89.
1999: Clemens J; Hoffman S; Ivanoff B; Klugman K; Levine M M; Neira M; Pang T
Typhoid fever vaccines.
Vaccine 1999;17(20-21):2476-8.
1999: Prado V; Lagos R; Nataro J P; San Martin O; Arellano C; Wang J Y; Borczyk A A; Levine M M
Population-based study of the incidence of Shigella diarrhea and causative serotypes in Santiago, Chile.
The Pediatric infectious disease journal 1999;18(6):500-5.
1999: Taylor D N; Sanchez J L; Castro J M; Lebron C; Parrado C M; Johnson D E; Tacket C O; Losonsky G A; Wasserman S S; Levine M M; Cryz S J
Expanded safety and immunogenicity of a bivalent, oral, attenuated cholera vaccine, CVD 103-HgR plus CVD 111, in United States military personnel stationed in Panama.
Infection and immunity 1999;67(4):2030-4.
1999: Levine M M; Cohen D; Green M; Levine O S; Mintz E D
Fly control and shigellosis.
Lancet 1999;353(9157):1020.
1999: Rios M; Prado V; Trucksis M; Arellano C; Borie C; Alexandre M; Fica A; Levine M M
Clonal diversity of Chilean isolates of enterohemorrhagic Escherichia coli from patients with hemolytic-uremic syndrome, asymptomatic subjects, animal reservoirs, and food products.
Journal of clinical microbiology 1999;37(3):778-81.
1999: Noriega F R; Liao F M; Maneval D R; Ren S; Formal S B; Levine M M
Strategy for cross-protection among Shigella flexneri serotypes.
Infection and immunity 1999;67(2):782-8.
1999: Levine M M; Curran J
HIV vaccines and prevention in a world without Mary Lou Clements-Mann and Jonathan Mann.
Journal of human virology 1999;2(1):58-60.
1999: Tang C; Moxon R; Levine M M
For discussion: live attenuated vaccines for group B meningococcus.
Vaccine 1999;17(2):114-7.
1999: Kotloff K L; Winickoff J P; Ivanoff B; Clemens J D; Swerdlow D L; Sansonetti P J; Adak G K; Levine M M
Global burden of Shigella infections: implications for vaccine development and implementation of control strategies.
Bulletin of the World Health Organization 1999;77(8):651-66.
1998: Prado V; Pidal P; Arellano C; Lagos R; San Martin O; Levine M M
[Antimicrobial multiresistance of Shigella sp strains in a semi rural community of northern Santiago]
Revista médica de Chile 1998;126(12):1464-71.
1998: Lagos R; Levine O S; Avendaño A; Horwitz I; Levine M M
The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries.
The Pediatric infectious disease journal 1998;17(9 Suppl):S139-48.
1998: González C R; Noriega F R; Huerta S; Santiago A; Vega M; Paniagua J; Ortiz-Navarrete V; Isibasi A; Levine M M
Immunogenicity of a Salmonella typhi CVD 908 candidate vaccine strain expressing the major surface protein gp63 of Leishmania mexicana mexicana.
Vaccine 1998;16(9-10):1043-52.
1998: Hoppenbrouwers K; Lagos R; Swennen B; Ethevenaux C; Knops J; Levine M M; Desmyter J
Safety and immunogenicity of an Haemophilus influenzae type b-tetanus toxoid conjugate (PRP-T) and diphtheria-tetanus-pertussis (DTP) combination vaccine administered in a dual-chamber syringe to infants in Belgium and Chile.
Vaccine 1998;16(9-10):921-7.
1998: Lagos R; Valenzuela M T; Levine O S; Losonsky G A; Erazo A; Wasserman S S; Levine M M
Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
Lancet 1998;351(9114):1472-6.
1998: Levine M M; Dougan G
Optimism over vaccines administered via mucosal surfaces.
Lancet 1998;351(9113):1375-6.
1998: Tacket C O; Mason H S; Losonsky G; Clements J D; Levine M M; Arntzen C J
Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato.
Nature medicine 1998;4(5):607-9.
1998: Sack D A; Tacket C O; Cohen M B; Sack R B; Losonsky G A; Shimko J; Nataro J P; Edelman R; Levine M M; Giannella R A; Schiff G; Lang D
Validation of a volunteer model of cholera with frozen bacteria as the challenge.
Infection and immunity 1998;66(5):1968-72.
1998: Pang T; Levine M M; Ivanoff B; Wain J; Finlay B B
Typhoid fever--important issues still remain.
Trends in microbiology 1998;6(4):131-3.
1998: Lagos R; Kotloff K; Hoffenbach A; San Martin O; Abrego P; Ureta A M; Pines E; Blondeau C; Bailleux F; Levine M M
Clinical acceptability and immunogenicity of a pentavalent parenteral combination vaccine containing diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis and Haemophilus influenzae type b conjugate antigens in two-, four- and six-month-old Chilean infants.
The Pediatric infectious disease journal 1998;17(4):294-304.
1998: Levine M M; Lagos R; Levine O S; Heitmann I; Enriquez N; Pinto M E; Alvarez A M; Wu E; Mayorga C; Reyes A
Epidemiology of invasive pneumococcal infections in infants and young children in Metropolitan Santiago, Chile, a newly industrializing country.
The Pediatric infectious disease journal 1998;17(4):287-93.
1998: Tacket C O; Taylor R K; Losonsky G; Lim Y; Nataro J P; Kaper J B; Levine M M
Investigation of the roles of toxin-coregulated pili and mannose-sensitive hemagglutinin pili in the pathogenesis of Vibrio cholerae O139 infection.
Infection and immunity 1998;66(2):692-5.
1998: Donnenberg M S; Tacket C O; Losonsky G; Frankel G; Nataro J P; Dougan G; Levine M M
Effect of prior experimental human enteropathogenic Escherichia coli infection on illness following homologous and heterologous rechallenge.
Infection and immunity 1998;66(1):52-8.
1998: Levine M M
Experimental challenge studies in the development of vaccines for infectious diseases.
Developments in biological standardization 1998;95():169-74.
1998: Perry R T; Plowe C V; Koumaré B; Bougoudogo F; Kotloff K L; Losonsky G A; Wasserman S S; Levine M M
A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and HIV-noninfected adults in Mali.
Bulletin of the World Health Organization 1998;76(1):63-71.
1997: Levine M M; Levine O S
Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use.
Lancet 1997;350(9088):1386-92.
1997: Taylor D N; Tacket C O; Losonsky G; Castro O; Gutierrez J; Meza R; Nataro J P; Kaper J B; Wasserman S S; Edelman R; Levine M M; Cryz S J
Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.
Infection and immunity 1997;65(9):3852-6.
1997: Tacket C O; Kelly S M; Schödel F; Losonsky G; Nataro J P; Edelman R; Levine M M; Curtiss R
Safety and immunogenicity in humans of an attenuated Salmonella typhi vaccine vector strain expressing plasmid-encoded hepatitis B antigens stabilized by the Asd-balanced lethal vector system.
Infection and immunity 1997;65(8):3381-5.
1997: Tacket C O; Kotloff K L; Losonsky G; Nataro J P; Michalski J; Kaper J B; Edelman R; Levine M M
Volunteer studies investigating the safety and efficacy of live oral El Tor Vibrio cholerae O1 vaccine strain CVD 111.
The American journal of tropical medicine and hygiene 1997;56(5):533-7.
1997: Losonsky G A; Lim Y; Motamedi P; Comstock L E; Johnson J A; Morris J G; Tacket C O; Kaper J B; Levine M M
Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: specificity and relevance to immunity.
Clinical and diagnostic laboratory immunology 1997;4(3):264-9.
1997: Galen J E; Gomez-Duarte O G; Losonsky G A; Halpern J L; Lauderbaugh C S; Kaintuck S; Reymann M K; Levine M M
A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
Vaccine 1997;15(6-7):700-8.
1997: Fasano A; Noriega F R; Liao F M; Wang W; Levine M M
Effect of shigella enterotoxin 1 (ShET1) on rabbit intestine in vitro and in vivo.
Gut 1997;40(4):505-11.
1997: Prado V; Martínez J; Arellano C; Levine M M
[Temporal variation of genotypes and serotypes of enterohemorrhagic E Coli isolated from Chilean children with intestinal infections or hemolytic uremic syndrome]
Revista médica de Chile 1997;125(3):291-7.
1997: Levine M M; Galen J; Barry E; Noriega F; Tacket C; Sztein M; Chatfield S; Dougan G; Losonsky G; Kotloff K
Attenuated Salmonella typhi and Shigella as live oral vaccines and as live vectors.
Behring Institute Mitteilungen 1997;(98):120-3.
1997: Levine O S; Granoff D M; Lagos R; Fritzell B; Levine M M
Factors associated with superior antibody responses to a single dose of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine administered to Chilean infants at 2 months of age.
Vaccine 1997;15(3):325-8.
1997: Cookson S T; Stamboulian D; Demonte J; Quero L; Martinez de Arquiza C; Aleman A; Lepetic A; Levine M M
A cost-benefit analysis of programmatic use of CVD 103-HgR live oral cholera vaccine in a high-risk population.
International journal of epidemiology 1997;26(1):212-9.
1997: Tacket C O; Sztein M B; Losonsky G A; Wasserman S S; Nataro J P; Edelman R; Pickard D; Dougan G; Chatfield S N; Levine M M
Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans.
Infection and immunity 1997;65(2):452-6.
1997: Levine M M
Oral vaccines against cholera: lessons from Vietnam and elsewhere.
Lancet 1997;349(9047):220-1.
1996: Levine O S; Lagos R; Losonsky G A; San Martin O; Abrego P; Bustamante C; Wasserman S S; Levine M M
No adverse impact on protection against pertussis from combined administration of Haemophilus influenza type b conjugate and diphtheria-tetanus toxoid-pertussis vaccines in the same syringe.
The Journal of infectious diseases 1996;174(6):1341-4.
1996: Kotloff K L; Noriega F; Losonsky G A; Sztein M B; Wasserman S S; Nataro J P; Levine M M
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG.
Infection and immunity 1996;64(11):4542-8.
1996: Barry E M; Gomez-Duarte O; Chatfield S; Rappuoli R; Pizza M; Losonsky G; Galen J; Levine M M
Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
Infection and immunity 1996;64(10):4172-81.
1996: Makarova O; Gorneva G; Wu F; Farutin V; Villeponteau B; Poliani L; Fink D; Levine M
Incorporation of nuclear matrix attachment regions into the herpes simplex virus type 1 genome does not induce long-term expression of a foreign gene during latency.
Gene therapy 1996;3(9):829-33.
1996: Cegielski J P; Msengi A E; Dukes C S; Levine M M
Pathogenic Escherichia coli in children with and without chronic diarrhea in Tanzania.
The Journal of infectious diseases 1996;174(3):675-7.
1996: Ramakrishnan R; Poliani P L; Levine M; Glorioso J C; Fink D J
Detection of herpes simplex virus type 1 latency-associated transcript expression in trigeminal ganglia by in situ reverse transcriptase PCR.
Journal of virology 1996;70(9):6519-23.
1996: Noriega F R; Losonsky G; Lauderbaugh C; Liao F M; Wang J Y; Levine M M
Engineered deltaguaB-A deltavirG Shigella flexneri 2a strain CVD 1205: construction, safety, immunogenicity, and potential efficacy as a mucosal vaccine.
Infection and immunity 1996;64(8):3055-61.
1996: Savarino S J; McVeigh A; Watson J; Cravioto A; Molina J; Echeverria P; Bhan M K; Levine M M; Fasano A
Enteroaggregative Escherichia coli heat-stable enterotoxin is not restricted to enteroaggregative E. coli.
The Journal of infectious diseases 1996;173(4):1019-22.
1996: Lagos R; Horwitz I; Toro J; San Martin O; Abrego P; Bustamante C; Wasserman S S; Levine O S; Levine M M
Large scale, postlicensure, selective vaccination of Chilean infants with PRP-T conjugate vaccine: practicality and effectiveness in preventing invasive Haemophilus influenzae type b infections.
The Pediatric infectious disease journal 1996;15(3):216-22.
1996: Levine M M; Galen J; Barry E; Noriega F; Chatfield S; Sztein M; Dougan G; Tacket C
Attenuated Salmonella as live oral vaccines against typhoid fever and as live vectors.
Journal of biotechnology 1996;44(1-3):193-6.
1996: Acheson D W; Levine M M; Kaper J B; Keusch G T
Protective immunity to Shiga-like toxin I following oral immunization with Shiga-like toxin I B-subunit-producing Vibrio cholerae CVD 103-HgR.
Infection and immunity 1996;64(1):355-7.
1996: Noriega F R; Losonsky G; Wang J Y; Formal S B; Levine M M
Further characterization of delta aroA delta virG Shigella flexneri 2a strain CVD 1203 as a mucosal Shigella vaccine and as a live-vector vaccine for delivering antigens of enterotoxigenic Escherichia coli.
Infection and immunity 1996;64(1):23-7.
1996: Losonsky G A; Yunyongying J; Lim V; Reymann M; Lim Y L; Wasserman S S; Levine M M
Factors influencing secondary vibriocidal immune responses: relevance for understanding immunity to cholera.
Infection and immunity 1996;64(1):10-5.
1995: Levine M M; Noriega F
A review of the current status of enteric vaccines.
Papua and New Guinea medical journal 1995;38(4):325-31.
1995: Wu S; Pascual D W; VanCott J L; McGhee J R; Maneval D R; Levine M M; Hone D M
Immune responses to novel Escherichia coli and Salmonella typhimurium vectors that express colonization factor antigen I (CFA/I) of enterotoxigenic E. coli in the absence of the CFA/I positive regulator cfaR.
Infection and immunity 1995;63(12):4933-8.
1995: Nataro J P; Seriwatana J; Fasano A; Maneval D R; Guers L D; Noriega F; Dubovsky F; Levine M M; Morris J G
Identification and cloning of a novel plasmid-encoded enterotoxin of enteroinvasive Escherichia coli and Shigella strains.
Infection and immunity 1995;63(12):4721-8.
1995: Gómez-Duarte O G; Galen J; Chatfield S N; Rappuoli R; Eidels L; Levine M M
Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain.
Vaccine 1995;13(16):1596-602.
1995: Kotloff K L; Nataro J P; Losonsky G A; Wasserman S S; Hale T L; Taylor D N; Sadoff J C; Levine M M
A modified Shigella volunteer challenge model in which the inoculum is administered with bicarbonate buffer: clinical experience and implications for Shigella infectivity.
Vaccine 1995;13(16):1488-94.
1995: Noriega F R; Liao F M; Formal S B; Fasano A; Levine M M
Prevalence of Shigella enterotoxin 1 among Shigella clinical isolates of diverse serotypes.
The Journal of infectious diseases 1995;172(5):1408-10.
1995: Sztein M B; Tanner M K; Polotsky Y; Orenstein J M; Levine M M
Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans.
Journal of immunology (Baltimore, Md. : 1950) 1995;155(8):3987-93.
1995: Girón J A; Viboud G I; Sperandio V; Gómez-Duarte O G; Maneval D R; Albert M J; Levine M M; Kaper J B
Prevalence and association of the longus pilus structural gene (lngA) with colonization factor antigens, enterotoxin types, and serotypes of enterotoxigenic Escherichia coli.
Infection and immunity 1995;63(10):4195-8.
1995: Prado V; Basualdo W; Arellano C; Martínez J; Levine M M
[In vitro susceptibility of enterohemorrhagic Escherichia coli to 11 antimicrobials. Relationship between antibiotic resistance and toxigenic genotype]
Revista médica de Chile 1995;123(9):1085-90.
1995: Tacket C O; Losonsky G; Nataro J P; Comstock L; Michalski J; Edelman R; Kaper J B; Levine M M
Initial clinical studies of CVD 112 Vibrio cholerae O139 live oral vaccine: safety and efficacy against experimental challenge.
The Journal of infectious diseases 1995;172(3):883-6.
1995: Glynn J R; Hornick R B; Levine M M; Bradley D J
Infecting dose and severity of typhoid: analysis of volunteer data and examination of the influence of the definition of illness used.
Epidemiology and infection 1995;115(1):23-30.
1995: Ojeda A; Prado V; Martinez J; Arellano C; Borczyk A; Johnson W; Lior H; Levine M M
Sorbitol-negative phenotype among enterohemorrhagic Escherichia coli strains of different serotypes and from different sources.
Journal of clinical microbiology 1995;33(8):2199-201.
1995: Girón J A; Xu J G; González C R; Hone D; Kaper J B; Levine M M
Simultaneous expression of CFA/I and CS3 colonization factor antigens of enterotoxigenic Escherichia coli by delta aroC, delta aroD Salmonella typhi vaccine strain CVD 908.
Vaccine 1995;13(10):939-46.
1995: Fasano A; Noriega F R; Maneval D R; Chanasongcram S; Russell R; Guandalini S; Levine M M
Shigella enterotoxin 1: an enterotoxin of Shigella flexneri 2a active in rabbit small intestine in vivo and in vitro.
The Journal of clinical investigation 1995;95(6):2853-61.
1995: Cryz S J; Que J U; Levine M M; Wiedermann G; Kollaritsch H
Safety and immunogenicity of a live oral bivalent typhoid fever (Salmonella typhi Ty21a)-cholera (Vibrio cholerae CVD 103-HgR) vaccine in healthy adults.
Infection and immunity 1995;63(4):1336-9.
1995: Kotloff K L; Losonsky G A; Nataro J P; Wasserman S S; Hale T L; Taylor D N; Newland J W; Sadoff J C; Formal S B; Levine M M
Evaluation of the safety, immunogenicity, and efficacy in healthy adults of four doses of live oral hybrid Escherichia coli-Shigella flexneri 2a vaccine strain EcSf2a-2.
Vaccine 1995;13(5):495-502.
1995: Nataro J P; Deng Y; Cookson S; Cravioto A; Savarino S J; Guers L D; Levine M M; Tacket C O
Heterogeneity of enteroaggregative Escherichia coli virulence demonstrated in volunteers.
The Journal of infectious diseases 1995;171(2):465-8.
1995: Lagos R; Avendaño A; Prado V; Horwitz I; Wasserman S; Losonsky G; Cryz S; Kaper J B; Levine M M
Attenuated live cholera vaccine strain CVD 103-HgR elicits significantly higher serum vibriocidal antibody titers in persons of blood group O.
Infection and immunity 1995;63(2):707-9.
1995: Tacket C O; Losonsky G; Nataro J P; Wasserman S S; Cryz S J; Edelman R; Levine M M
Extension of the volunteer challenge model to study South American cholera in a population of volunteers predominantly with blood group antigen O.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1995;89(1):75-7.
1995: Kaper J B; Morris J G; Levine M M
Cholera.
Clinical microbiology reviews 1995;8(1):48-86.
1995: Comstock L E; Maneval D; Panigrahi P; Joseph A; Levine M M; Kaper J B; Morris J G; Johnson J A
The capsule and O antigen in Vibrio cholerae O139 Bengal are associated with a genetic region not present in Vibrio cholerae O1.
Infection and immunity 1995;63(1):317-23.
1995: Levine M M
Non-target effects of live vaccines: myth, reality and demagoguery.
Developments in biological standardization 1995;84():33-8.
1995: Cryz S J; Kaper J; Tacket C; Nataro J; Levine M M
Vibrio cholerae CVD103-HgR live oral attenuated vaccine: construction, safety, immunogenicity, excretion and non-target effects.
Developments in biological standardization 1995;84():237-44.
1994: Sztein M B; Wasserman S S; Tacket C O; Edelman R; Hone D; Lindberg A A; Levine M M
Cytokine production patterns and lymphoproliferative responses in volunteers orally immunized with attenuated vaccine strains of Salmonella typhi.
The Journal of infectious diseases 1994;170(6):1508-17.
1994: Ramakrishnan R; Levine M; Fink D J
PCR-based analysis of herpes simplex virus type 1 latency in the rat trigeminal ganglion established with a ribonucleotide reductase-deficient mutant.
Journal of virology 1994;68(11):7083-91.
1994: Noriega F R; Wang J Y; Losonsky G; Maneval D R; Hone D M; Levine M M
Construction and characterization of attenuated delta aroA delta virG Shigella flexneri 2a strain CVD 1203, a prototype live oral vaccine.
Infection and immunity 1994;62(11):5168-72.
1994: Pickard D; Li J; Roberts M; Maskell D; Hone D; Levine M; Dougan G; Chatfield S
Characterization of defined ompR mutants of Salmonella typhi: ompR is involved in the regulation of Vi polysaccharide expression.
Infection and immunity 1994;62(9):3984-93.
1994: Wasserman S S; Losonsky G A; Noriega F; Tacket C O; Castañeda E; Levine M M
Kinetics of the vibriocidal antibody response to live oral cholera vaccines.
Vaccine 1994;12(11):1000-3.
1994: Hone D M; Harris A M; Levine M M
Adaptive acid tolerance response by Salmonella typhi and candidate live oral typhoid vaccine strains.
Vaccine 1994;12(10):895-8.
1994: Hone D M; Harris A M; Lim V; Levine M M
Construction and characterization of isogenic O-antigen variants of Salmonella typhi.
Molecular microbiology 1994;13(3):525-30.
1994: Medina E C; Widmalm G; Weintraub A; Vial P A; Levine M M; Lindberg A A
Structural studies of the O-antigenic polysaccharides of Escherichia coli O3 and the enteroaggregative Escherichia coli strain 17-2.
European journal of biochemistry / FEBS 1994;224(1):191-6.
1994: Goins W F; Sternberg L R; Croen K D; Krause P R; Hendricks R L; Fink D J; Straus S E; Levine M; Glorioso J C
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
Journal of virology 1994;68(4):2239-52.
1994: Kaper J B; Michalski J; Ketley J M; Levine M M
Potential for reacquisition of cholera enterotoxin genes by attenuated Vibrio cholerae vaccine strain CVD 103-HgR.
Infection and immunity 1994;62(4):1480-3.
1994: Girón J A; Levine M M; Kaper J B
Longus: a long pilus ultrastructure produced by human enterotoxigenic Escherichia coli.
Molecular microbiology 1994;12(1):71-82.
1994: Levine M M; Levine O S
Changes in human ecology and behavior in relation to the emergence of diarrheal diseases, including cholera.
Proceedings of the National Academy of Sciences of the United States of America 1994;91(7):2390-4.
1994: Ramakrishnan R; Fink D J; Jiang G; Desai P; Glorioso J C; Levine M
Competitive quantitative PCR analysis of herpes simplex virus type 1 DNA and latency-associated transcript RNA in latently infected cells of the rat brain.
Journal of virology 1994;68(3):1864-73.
1994: Curtiss R; Kelly S M; Tinge S A; Tacket C O; Levine M M; Srinivasan J; Koopman M
Recombinant Salmonella vectors in vaccine development.
Developments in biological standardization 1994;82():23-33.
1994: Ivanoff B; Levine M M; Lambert P H
Vaccination against typhoid fever: present status.
Bulletin of the World Health Organization 1994;72(6):957-71.
1993: Wasserman S S; Kotloff K L; Losonsky G A; Levine M M
Immunologic response to oral cholera vaccination in a crossover study: a novel placebo effect.
American journal of epidemiology 1993;138(11):988-93.
1993: Tacket C O; Losonsky G; Nataro J P; Cryz S J; Edelman R; Fasano A; Michalski J; Kaper J B; Levine M M
Safety and immunogenicity of live oral cholera vaccine candidate CVD 110, a delta ctxA delta zot delta ace derivative of El Tor Ogawa Vibrio cholerae.
The Journal of infectious diseases 1993;168(6):1536-40.
1993: Levine M M; Noriega F
Vaccines to prevent bacterial enteric infections in children.
Pediatric annals 1993;22(12):719-25.
1993: Levine M M; Ferreccio C; Prado V; Cayazzo M; Abrego P; Martinez J; Maggi L; Baldini M M; Martin W; Maneval D
Epidemiologic studies of Escherichia coli diarrheal infections in a low socioeconomic level peri-urban community in Santiago, Chile.
American journal of epidemiology 1993;138(10):849-69.
1993: Desai P; Ramakrishnan R; Lin Z W; Osak B; Glorioso J C; Levine M
The RR1 gene of herpes simplex virus type 1 is uniquely trans activated by ICP0 during infection.
Journal of virology 1993;67(10):6125-35.
1993: Donnenberg M S; Tacket C O; James S P; Losonsky G; Nataro J P; Wasserman S S; Kaper J B; Levine M M
Role of the eaeA gene in experimental enteropathogenic Escherichia coli infection.
The Journal of clinical investigation 1993;92(3):1412-7.
1993: Avendano A; Ferreccio C; Lagos R; Horwitz I; Cayazzo M; Fritzell B; Meschievitz C; Levine M
Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age.
The Pediatric infectious disease journal 1993;12(8):638-43.
1993: Mahle W T; Levine M M
Salmonella typhi infection in children younger than five years of age.
The Pediatric infectious disease journal 1993;12(8):627-31.
1993: Ketley J M; Michalski J; Galen J; Levine M M; Kaper J B
Construction of genetically marked Vibrio cholerae O1 vaccine strains.
FEMS microbiology letters 1993;111(1):15-21.
1993: Mackowiak P A; Wasserman S S; Levine M M
Relationship between humoral immune responses and oral temperature during human shigellosis.
The Journal of infectious diseases 1993;167(6):1449-52.
1993: Levine M M; Noriega F
Vaccines to prevent enteric infections.
Baillière's clinical gastroenterology 1993;7(2):501-17.
1993: Pongsunk S; Sarasombath S; Ekpo P; Tangtherawattana P; Levine M M
Production of monoclonal antibodies to Vi polysaccharide antigen of Salmonella typhi.
Asian Pacific journal of allergy and immunology / launched by the Allergy and Immunology Society of Thailand 1993;11(1):53-6.
1993: Wolf M K; Taylor D N; Boedeker E C; Hyams K C; Maneval D R; Levine M M; Tamura K; Wilson R A; Echeverria P
Characterization of enterotoxigenic Escherichia coli isolated from U.S. troops deployed to the Middle East.
Journal of clinical microbiology 1993;31(4):851-6.
1993: Savarino S J; Fasano A; Watson J; Martin B M; Levine M M; Guandalini S; Guerry P
Enteroaggregative Escherichia coli heat-stable enterotoxin 1 represents another subfamily of E. coli heat-stable toxin.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(7):3093-7.
1993: Gage P J; Levine M; Glorioso J C
Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B.
Journal of virology 1993;67(4):2191-201.
1993: Weintraub A; Leontein K; Widmalm G; Vial P A; Levine M M; Lindberg A A
Structural studies of the O-antigenic polysaccharide of an enteroaggregative Escherichia coli strain.
European journal of biochemistry / FEBS 1993;213(2):859-64.
1993: Cryz S J; Vanprapar N; Thisyakorn U; Olanratmanee T; Losonsky G; Levine M M; Chearskul S
Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.
Infection and immunity 1993;61(3):1149-51.
1993: Cohen M B; Hawkins J A; Weckbach L S; Staneck J L; Levine M M; Heck J E
Colonization by enteroaggregative Escherichia coli in travelers with and without diarrhea.
Journal of clinical microbiology 1993;31(2):351-3.
1993: Losonsky G A; Tacket C O; Wasserman S S; Kaper J B; Levine M M
Secondary Vibrio cholerae-specific cellular antibody responses following wild-type homologous challenge in people vaccinated with CVD 103-HgR live oral cholera vaccine: changes with time and lack of correlation with protection.
Infection and immunity 1993;61(2):729-33.
1993: Levine M M; Kaper J B
Live oral vaccines against cholera: an update.
Vaccine 1993;11(2):207-12.
1993: Edelman R; Russell R G; Losonsky G; Tall B D; Tacket C O; Levine M M; Lewis D H
Immunization of rabbits with enterotoxigenic E. coli colonization factor antigen (CFA/I) encapsulated in biodegradable microspheres of poly (lactide-co-glycolide).
Vaccine 1993;11(2):155-8.
1992: Tzipori S; Montanaro J; Robins-Browne R M; Vial P; Gibson R; Levine M M
Studies with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model.
Infection and immunity 1992;60(12):5302-6.
1992: Mackowiak P A; Wasserman S S; Levine M M
An analysis of the quantitative relationship between oral temperature and severity of illness in experimental shigellosis.
The Journal of infectious diseases 1992;166(5):1181-4.
1992: Tacket C O; Losonsky G; Nataro J P; Cryz S J; Edelman R; Kaper J B; Levine M M
Onset and duration of protective immunity in challenged volunteers after vaccination with live oral cholera vaccine CVD 103-HgR.
The Journal of infectious diseases 1992;166(4):837-41.
1992: Kotloff K L; Wasserman S S; O'Donnell S; Losonsky G A; Cryz S J; Levine M M
Safety and immunogenicity in North Americans of a single dose of live oral cholera vaccine CVD 103-HgR: results of a randomized, placebo-controlled, double-blind crossover trial.
Infection and immunity 1992;60(10):4430-2.
1992: Finch M J; Franco A; Gotuzzo E; Carrillo C; Benavente L; Wasserman S S; Levine M M; Morris J G
Plasmids in Salmonella typhi in Lima, Peru, 1987-1988: epidemiology and lack of association with severity of illness or clinical complications.
The American journal of tropical medicine and hygiene 1992;47(3):390-6.
1992: Cryz S J; Levine M M; Losonsky G; Kaper J B; Althaus B
Safety and immunogenicity of a booster dose of Vibrio cholerae CVD 103-HgR live oral cholera vaccine in Swiss adults.
Infection and immunity 1992;60(9):3916-7.
1992: Gage P J; Sauer B; Levine M; Glorioso J C
A cell-free recombination system for site-specific integration of multigenic shuttle plasmids into the herpes simplex virus type 1 genome.
Journal of virology 1992;66(9):5509-15.
1992: Mackowiak P A; Wasserman S S; Levine M M
A critical appraisal of 98.6 degrees F, the upper limit of the normal body temperature, and other legacies of Carl Reinhold August Wunderlich.
JAMA : the journal of the American Medical Association 1992;268(12):1578-80.
1992: Harpaz R; Edelman R; Wasserman S S; Levine M M; Davis J R; Sztein M B
Serum cytokine profiles in experimental human malaria. Relationship to protection and disease course after challenge.
The Journal of clinical investigation 1992;90(2):515-23.
1992: Hone D M; Tacket C O; Harris A M; Kay B; Losonsky G; Levine M M
Evaluation in volunteers of a candidate live oral attenuated Salmonella typhi vector vaccine.
The Journal of clinical investigation 1992;90(2):412-20.
1992: Olanratmanee T; Levine M; Losonsky G; Thisyakorn V; Cryz S J
Safety and immunogenicity of Salmonella typhi Ty21a liquid formulation vaccine in 4- to 6-year-old Thai children.
The Journal of infectious diseases 1992;166(2):451-2.
1992: Morris J G; Tacket C O; Levine M M
Oral carrier vaccines: new tricks in an old trade.
Gastroenterology 1992;103(2):699-702.
1992: Franco A; Gonzalez C; Levine O S; Lagos R; Hall R H; Hoffman S L; Moechtar M A; Gotuzzo E; Levine M M; Hone D M
Further consideration of the clonal nature of Salmonella typhi: evaluation of molecular and clinical characteristics of strains from Indonesia and Peru.
Journal of clinical microbiology 1992;30(8):2187-90.
1992: Cordovéz A; Prado V; Maggi L; Cordero J; Martinez J; Misraji A; Rios R; Soza G; Ojeda A; Levine M M
Enterohemorrhagic Escherichia coli associated with hemolytic-uremic syndrome in Chilean children.
Journal of clinical microbiology 1992;30(8):2153-7.
1992: Dolter K E; Goins W F; Levine M; Glorioso J C
Genetic analysis of type-specific antigenic determinants of herpes simplex virus glycoprotein C.
Journal of virology 1992;66(8):4864-73.
1992: Levine M M; McEwen J; Losonsky G; Reymann M; Harari I; Brown J E; Taylor D N; Donohue-Rolfe A; Cohen D; Bennish M
Antibodies to shiga holotoxin and to two synthetic peptides of the B subunit in sera of patients with Shigella dysenteriae 1 dysentery.
Journal of clinical microbiology 1992;30(7):1636-41.
1992: Van de Verg L L; Herrington D A; Boslego J; Lindberg A A; Levine M M
Age-specific prevalence of serum antibodies to the invasion plasmid and lipopolysaccharide antigens of Shigella species in Chilean and North American populations.
The Journal of infectious diseases 1992;166(1):158-61.
1992: Kotloff K L; Herrmann J E; Blacklow N R; Hudson R W; Wasserman S S; Morris J G; Levine M M
The frequency of astrovirus as a cause of diarrhea in Baltimore children.
The Pediatric infectious disease journal 1992;11(7):587-9.
1992: Kotloff K L; Herrington D A; Hale T L; Newland J W; Van De Verg L; Cogan J P; Snoy P J; Sadoff J C; Formal S B; Levine M M
Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen.
Infection and immunity 1992;60(6):2218-24.
1992: Nataro J P; Deng Y; Maneval D R; German A L; Martin W C; Levine M M
Aggregative adherence fimbriae I of enteroaggregative Escherichia coli mediate adherence to HEp-2 cells and hemagglutination of human erythrocytes.
Infection and immunity 1992;60(6):2297-304.
1992: Davis J R; Cortese J F; Herrington D A; Murphy J R; Clyde D F; Thomas A W; Baqar S; Cochran M A; Thanassi J; Levine M M
Plasmodium falciparum: in vitro characterization and human infectivity of a cloned line.
Experimental parasitology 1992;74(2):159-68.
1992: Clemens J D; Ferreccio C; Levine M M; Horwitz I; Rao M R; Edwards K M; Fritzell B
Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.
JAMA : the journal of the American Medical Association 1992;267(5):673-8.
1992: Tacket C O; Hone D M; Curtiss R; Kelly S M; Losonsky G; Guers L; Harris A M; Edelman R; Levine M M
Comparison of the safety and immunogenicity of delta aroC delta aroD and delta cya delta crp Salmonella typhi strains in adult volunteers.
Infection and immunity 1992;60(2):536-41.
1992: Contreras R; Ferreccio C; Sotomayor V; Astroza L; Berríos G; Ortiz E; Palomino C; Prenzel I; Pinto M E; Levine M
[Typhoid fever in school children: by what measures is the modification of the clinical course due to oral vaccination?]
Revista médica de Chile 1992;120(2):134-41.
1992: Echeverria P; Serichantalerg O; Changchawalit S; Baudry B; Levine M M; Orskov F; Orskov I
Tissue culture-adherent Escherichia coli in infantile diarrhea.
The Journal of infectious diseases 1992;165(1):141-3.
1992: Tacket C O; Hone D M; Losonsky G A; Guers L; Edelman R; Levine M M
Clinical acceptability and immunogenicity of CVD 908 Salmonella typhi vaccine strain.
Vaccine 1992;10(7):443-6.
1992: Tacket C O; Losonsky G; Lubeck M D; Davis A R; Mizutani S; Horwith G; Hung P; Edelman R; Levine M M
Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine.
Vaccine 1992;10(10):673-6.
1992: Herrington D A; Losonsky G A; Smith G; Volvovitz F; Cochran M; Jackson K; Hoffman S L; Gordon D M; Levine M M; Edelman R
Safety and immunogenicity in volunteers of a recombinant Plasmodium falciparum circumsporozoite protein malaria vaccine produced in Lepidopteran cells.
Vaccine 1992;10(12):841-6.
1992: Chatfield S N; Fairweather N; Charles I; Pickard D; Levine M; Hone D; Posada M; Strugnell R A; Dougan G
Construction of a genetically defined Salmonella typhi Ty2 aroA, aroC mutant for the engineering of a candidate oral typhoid-tetanus vaccine.
Vaccine 1992;10(1):53-60.
1991: Lagos R; Avendano A; Horwitz I; Musser J M; Hoiseth S K; Maneval D R; Jones M J; Levine M M; Dattas J P; Prenzel I
Molecular epidemiology of Haemophilus influenzae within families in Santiago, Chile.
The Journal of infectious diseases 1991;164(6):1149-53.
1991: Herrington D A; Nardin E H; Losonsky G; Bathurst I C; Barr P J; Hollingdale M R; Edelman R; Levine M M
Safety and immunogenicity of a recombinant sporozoite malaria vaccine against Plasmodium vivax.
The American journal of tropical medicine and hygiene 1991;45(6):695-701.
1991: Morris J G; Prado V; Ferreccio C; Robins-Browne R M; Bordun A M; Cayazzo M; Kay B A; Levine M M
Yersinia enterocolitica isolated from two cohorts of young children in Santiago, Chile: incidence of and lack of correlation between illness and proposed virulence factors.
Journal of clinical microbiology 1991;29(12):2784-8.
1991: Herrington D; Davis J; Nardin E; Beier M; Cortese J; Eddy H; Losonsky G; Hollingdale M; Sztein M; Levine M
Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.
The American journal of tropical medicine and hygiene 1991;45(5):539-47.
1991: Murphy J R; Grez L; Schlesinger L; Ferreccio C; Baqar S; Muñoz C; Wasserman S S; Losonsky G; Olson J G; Levine M M
Immunogenicity of Salmonella typhi Ty21a vaccine for young children.
Infection and immunity 1991;59(11):4291-3.
1991: Hone D M; Harris A M; Chatfield S; Dougan G; Levine M M
Construction of genetically defined double aro mutants of Salmonella typhi.
Vaccine 1991;9(11):810-6.
1991: Ferreccio C; Clemens J; Avendano A; Horwitz I; Flores C; Avila L; Cayazzo M; Fritzell B; Cadoz M; Levine M
The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.
The Pediatric infectious disease journal 1991;10(10):764-71.
1991: Ferreccio C; Prado V; Ojeda A; Cayyazo M; Abrego P; Guers L; Levine M M
Epidemiologic patterns of acute diarrhea and endemic Shigella infections in children in a poor periurban setting in Santiago, Chile.
American journal of epidemiology 1991;134(6):614-27.
1991: Highlander S L; Goins W F; Person S; Holland T C; Levine M; Glorioso J C
Oligomer formation of the gB glycoprotein of herpes simplex virus type 1.
Journal of virology 1991;65(8):4275-83.
1991: Levine O S; Levine M M
Houseflies (Musca domestica) as mechanical vectors of shigellosis.
Reviews of infectious diseases 1991;13(4):688-96.
1991: Hall R H; Losonsky G; Silveira A P; Taylor R K; Mekalanos J J; Witham N D; Levine M M
Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.
Infection and immunity 1991;59(7):2508-12.
1991: Tacket C O; Losonsky G; Taylor D N; Baron L S; Kopecko D; Cryz S; Levine M M
Lack of immune response to the Vi component of a Vi-positive variant of the Salmonella typhi live oral vaccine strain Ty21a in human studies.
The Journal of infectious diseases 1991;163(4):901-4.
1991: Savarino S J; Fasano A; Robertson D C; Levine M M
Enteroaggregative Escherichia coli elaborate a heat-stable enterotoxin demonstrable in an in vitro rabbit intestinal model.
The Journal of clinical investigation 1991;87(4):1450-5.
1991: Levine M M
Vaccines and milk immunoglobulin concentrates for prevention of infectious diarrhea.
The Journal of pediatrics 1991;118(4 ( Pt 2)):S129-36.
1991: Cohen D; Green M; Block C; Slepon R; Ambar R; Wasserman S S; Levine M M
Reduction of transmission of shigellosis by control of houseflies (Musca domestica)
Lancet 1991;337(8748):993-7.
1991: Edelman R; Levine M M
Enteric vaccines.
Maryland medical journal (Baltimore, Md. : 1985) 1991;40(3):199-203.
1991: Servos S; Chatfield S; Hone D; Levine M; Dimitriadis G; Pickard D; Dougan G; Fairweather N; Charles I
Molecular cloning and characterization of the aroD gene encoding 3-dehydroquinase from Salmonella typhi.
Journal of general microbiology 1991;137(1):147-52.
1990: Cryz S J; Levine M M; Kaper J B; Fürer E; Althaus B
Randomized double-blind placebo controlled trial to evaluate the safety and immunogenicity of the live oral cholera vaccine strain CVD 103-HgR in Swiss adults.
Vaccine 1990;8(6):577-80.
1990: Gicquelais K G; Baldini M M; Martinez J; Maggi L; Martin W C; Prado V; Kaper J B; Levine M M
Practical and economical method for using biotinylated DNA probes with bacterial colony blots to identify diarrhea-causing Escherichia coli.
Journal of clinical microbiology 1990;28(11):2485-90.
1990: Levine M M; Ferreccio C; Cryz S; Ortiz E
Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial.
Lancet 1990;336(8720):891-4.
1990: Kaper J B; Levine M M
Recombinant attenuated Vibrio cholerae strains used as live oral vaccines.
Research in microbiology 1990;141(7-8):901-6.
1990: Levine M M; Hone D; Tacket C; Ferreccio C; Cryz S
Clinical and field trials with attenuated Salmonella typhi as live oral vaccines and as "carrier" vaccines.
Research in microbiology 1990;141(7-8):807-16.
1990: Herrington D A; Van de Verg L; Formal S B; Hale T L; Tall B D; Cryz S J; Tramont E C; Levine M M
Studies in volunteers to evaluate candidate Shigella vaccines: further experience with a bivalent Salmonella typhi-Shigella sonnei vaccine and protection conferred by previous Shigella sonnei disease.
Vaccine 1990;8(4):353-7.
1990: Tacket C O; Moseley S L; Kay B; Losonsky G; Levine M M
Challenge studies in volunteers using Escherichia coli strains with diffuse adherence to HEp-2 cells.
The Journal of infectious diseases 1990;162(2):550-2.
1990: Kimmel K A; Dolter K E; Toth G M; Levine M; Glorioso J C
Serologic type conversion of a herpes simplex virus type 1 (HSV-1) to an HSV-2 epitope caused by a single amino acid substitution in glycoprotein C.
Journal of virology 1990;64(8):4033-6.
1990: Ferreccio C; Ortiz E; Astroza L; Rivera C; Clemens J; Levine M M
A population-based retrospective assessment of the disease burden resulting from invasive Haemophilus influenzae in infants and young children in Santiago, Chile.
The Pediatric infectious disease journal 1990;9(7):488-94.
1990: Nash T E; Herrington D A; Levine M M; Conrad J T; Merritt J W
Antigenic variation of Giardia lamblia in experimental human infections.
Journal of immunology (Baltimore, Md. : 1950) 1990;144(11):4362-9.
1990: Baudry B; Savarino S J; Vial P; Kaper J B; Levine M M
A sensitive and specific DNA probe to identify enteroaggregative Escherichia coli, a recently discovered diarrheal pathogen.
The Journal of infectious diseases 1990;161(6):1249-51.
1990: Van de Verg L; Herrington D A; Murphy J R; Wasserman S S; Formal S B; Levine M M
Specific immunoglobulin A-secreting cells in peripheral blood of humans following oral immunization with a bivalent Salmonella typhi-Shigella sonnei vaccine or infection by pathogenic S. sonnei.
Infection and immunity 1990;58(6):2002-4.
1990: Tacket C O; Forrest B; Morona R; Attridge S R; LaBrooy J; Tall B D; Reymann M; Rowley D; Levine M M
Safety, immunogenicity, and efficacy against cholera challenge in humans of a typhoid-cholera hybrid vaccine derived from Salmonella typhi Ty21a.
Infection and immunity 1990;58(6):1620-7.
1990: Rennels M B; Losonsky G A; Young A E; Shindledecker C L; Kapikian A Z; Levine M M
An efficacy trial of the rhesus rotavirus vaccine in Maryland. The Clinical Study Group.
American journal of diseases of children (1960) 1990;144(5):601-4.
1990: Ketley J M; Kaper J B; Herrington D A; Losonsky G; Levine M M
Diminished immunogenicity of a recombination-deficient derivative of Vibrio cholerae vaccine strain CVD103.
Infection and immunity 1990;58(5):1481-4.
1990: Vial P A; Mathewson J J; DuPont H L; Guers L; Levine M M
Comparison of two assay methods for patterns of adherence to HEp-2 cells of Escherichia coli from patients with diarrhea.
Journal of clinical microbiology 1990;28(5):882-5.
1990: Levine M M
Modern vaccines. Enteric infections.
Lancet 1990;335(8695):958-61.
1990: Vial P A; Kotloff K L; Tall B D; Morris J G; Levine M M
Detection by immune electron microscopy of 27-nm viral particles associated with community-acquired diarrhea in children.
The Journal of infectious diseases 1990;161(3):571-3.
1990: Levine M M; Edelman R
Future vaccines against enteric pathogens.
Infectious disease clinics of North America 1990;4(1):105-21.
1990: Black R E; Levine M M; Ferreccio C; Clements M L; Lanata C; Rooney J; Germanier R
Efficacy of one or two doses of Ty21a Salmonella typhi vaccine in enteric-coated capsules in a controlled field trial. Chilean Typhoid Committee.
Vaccine 1990;8(1):81-4.
1990: Wu C T; Levine M; Homa F; Highlander S L; Glorioso J C
Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.
Journal of virology 1990;64(2):856-63.
1990: Weber P C; Levine M; Glorioso J C
Recombinogenic properties of herpes simplex virus type 1 DNA sequences resident in simian virus 40 minichromosomes.
Journal of virology 1990;64(1):300-6.
1990: Ferreccio C; Levine M; Astroza L; Berrios G; Solari V; Misraji A; Pefaur C
[The detection of chronic Salmonella typhi carriers: a practical method applied to food handlers]
Revista médica de Chile 1990;118(1):33-7.
1990: Nardin E H; Nussenzweig R S; Altszuler R; Herrington D; Levine M; Murphy J; Davis J; Bathurst I; Barr P; Romero P
Cellular and humoral immune responses to a recombinant P. falciparum CS protein in sporozoite-immunized rodents and human volunteers.
Bulletin of the World Health Organization 1990;68 Suppl():85-7.
1990: Levine M; Krikos A; Glorioso J C; Homa F L
Regulation of expression of the glycoprotein genes of herpes simplex virus type 1 (HSV-1).
Advances in experimental medicine and biology 1990;278():151-64.
1989: Di John D; Wasserman S S; Torres J R; Cortesia M J; Murillo J; Losonsky G A; Herrington D A; Stürcher D; Levine M M
Effect of priming with carrier on response to conjugate vaccine.
Lancet 1989;2(8677):1415-8.
1989: Davis J R; Murphy J R; Baqar S; Clyde D F; Herrington D A; Levine M M
Estimate of anti-Plasmodium falciparum sporozoite activity in humans vaccinated with synthetic circumsporozoite protein (NANP)3.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1989;83(6):748-50.
1989: Hall R H; Maneval D R; Collins J H; Theibert J L; Levine M M
Purification and analysis of colonization factor antigen I, coli surface antigen 1, and coli surface antigen 3 fimbriae from enterotoxigenic Escherichia coli.
Journal of bacteriology 1989;171(11):6372-4.
1989: Sharma D P; Thomas C; Hall R H; Levine M M; Attridge S R
Significance of toxin-coregulated pili as protective antigens of Vibrio cholerae in the infant mouse model.
Vaccine 1989;7(5):451-6.
1989: Palella T D; Hidaka Y; Silverman L J; Levine M; Glorioso J; Kelley W N
Expression of human HPRT mRNA in brains of mice infected with a recombinant herpes simplex virus-1 vector.
Gene 1989;80(1):137-44.
1989: Kotloff K L; Losonsky G A; Morris J G; Wasserman S S; Singh-Naz N; Levine M M
Enteric adenovirus infection and childhood diarrhea: an epidemiologic study in three clinical settings.
Pediatrics 1989;84(2):219-25.
1989: Weber P C; Levine M; Glorioso J C
A rapid and sensitive method for plasmid copy number comparisons.
Nucleic acids research 1989;17(14):5866.
1989: Levine M M; Taylor D N; Ferreccio C
Typhoid vaccines come of age.
The Pediatric infectious disease journal 1989;8(6):374-81.
1989: DuPont H L; Levine M M; Hornick R B; Formal S B
Inoculum size in shigellosis and implications for expected mode of transmission.
The Journal of infectious diseases 1989;159(6):1126-8.
1989: Bhan M K; Raj P; Levine M M; Kaper J B; Bhandari N; Srivastava R; Kumar R; Sazawal S
Enteroaggregative Escherichia coli associated with persistent diarrhea in a cohort of rural children in India.
The Journal of infectious diseases 1989;159(6):1061-4.
1989: Chrisp C E; Sunstrum J C; Averill D R; Levine M; Glorioso J C
Characterization of encephalitis in adult mice induced by intracerebral inoculation of herpes simplex virus type 1 (KOS) and comparison with mutants showing decreased virulence.
Laboratory investigation; a journal of technical methods and pathology 1989;60(6):822-30.
1989: Levine M M; Ferreccio C; Black R E; Tacket C O; Germanier R
Progress in vaccines against typhoid fever.
Reviews of infectious diseases 1989;11 Suppl 3():S552-67.
1989: Ferreccio C; Levine M M; Rodriguez H; Contreras R
Comparative efficacy of two, three, or four doses of TY21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area.
The Journal of infectious diseases 1989;159(4):766-9.
1989: Richardson K; Kaper J B; Levine M M
Human immune response to Vibrio cholerae O1 whole cells and isolated outer membrane antigens.
Infection and immunity 1989;57(2):495-501.
1989: Murphy J R; Wasserman S S; Baqar S; Schlesinger L; Ferreccio C; Lindberg A A; Levine M M
Immunity to Salmonella typhi: considerations relevant to measurement of cellular immunity in typhoid-endemic regions.
Clinical and experimental immunology 1989;75(2):228-33.
1989: Highlander S L; Dorney D J; Gage P J; Holland T C; Cai W; Person S; Levine M; Glorioso J C
Identification of mar mutations in herpes simplex virus type 1 glycoprotein B which alter antigenic structure and function in virus penetration.
Journal of virology 1989;63(2):730-8.
1989: Wolf M K; Andrews G P; Tall B D; McConnell M M; Levine M M; Boedeker E C
Characterization of CS4 and CS6 antigenic components of PCF8775, a putative colonization factor complex from enterotoxigenic Escherichia coli E8775.
Infection and immunity 1989;57(1):164-73.
1989: Bhan M K; Bhandari N; Sazawal S; Clemens J; Raj P; Levine M M; Kaper J B
Descriptive epidemiology of persistent diarrhoea among young children in rural northern India.
Bulletin of the World Health Organization 1989;67(3):281-8.
1989: Hidaka Y; Kelley W N; Levine M; Glorioso J; Silverman L J; Palella T D
Expression of human hypoxanthine guanine phosphoribosyltransferase mRNA in brains of mice infected with a recombinant herpes simplex virus type 1.
Transactions of the Association of American Physicians 1989;102():91-100.
1989: Palella T D; Silverman L J; Homa F L; Levine M; Kelley W N
Transfer of human HPRT gene sequences into neuronal cells by a herpes simplex virus derived vector.
Advances in experimental medicine and biology 1989;253A():549-54.
1988: Kotloff K L; Wasserman S S; Steciak J Y; Tall B D; Losonsky G A; Nair P; Morris J G; Levine M M
Acute diarrhea in Baltimore children attending an outpatient clinic.
The Pediatric infectious disease journal 1988;7(11):753-9.
1988: Finch M J; Morris J G; Kaviti J; Kagwanja W; Levine M M
Epidemiology of antimicrobial resistant cholera in Kenya and East Africa.
The American journal of tropical medicine and hygiene 1988;39(5):484-90.
1988: Huff V; Cai W; Glorioso J C; Levine M
The carboxy-terminal 41 amino acids of herpes simplex virus type 1 glycoprotein B are not essential for production of infectious virus particles.
Journal of virology 1988;62(11):4403-6.
1988: Herrington D A; Hall R H; Losonsky G; Mekalanos J J; Taylor R K; Levine M M
Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.
The Journal of experimental medicine 1988;168(4):1487-92.
1988: Weber P C; Levine M; Glorioso J C
Simple assay for quantitation of Tn5 inversion events in Escherichia coli and use of the assay in determination of plasmid copy number.
Journal of bacteriology 1988;170(10):4972-5.
1988: Ferreccio C; Berríos G; Levine M; García J; Silva W; Rodríguez H
[Typhoid fever in Santiago: the role of food handlers at elementary schools]
Revista médica de Chile 1988;116(9):952-6.
1988: Levine M M; Kaper J B; Herrington D; Losonsky G; Tacket C; Tall B
The current status of cholera vaccine development and experience with cholera vaccine trials in volunteers.
The Southeast Asian journal of tropical medicine and public health 1988;19(3):401-15.
1988: Di John D; Levine M M
Treatment of diarrhea.
Infectious disease clinics of North America 1988;2(3):719-45.
1988: Levine M M; Tacket C O; Herrington D; Losonsky G; Murphy J; Ferreccio C
The current status of typhoid vaccine development and clinical trials with typhoid vaccines.
The Southeast Asian journal of tropical medicine and public health 1988;19(3):459-69.
1988: Levine M M; Herrington D; Clyde D; Murphy J; Davis J; Nussenzweig R; Nardin E; Felix A; Heimer E; Gillesen D
Malaria vaccines: experience with sporozoite vaccines against falciparum malaria.
The Southeast Asian journal of tropical medicine and public health 1988;19(3):369-74.
1988: Tacket C O; Levine M M; Robbins J B
Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
Vaccine 1988;6(4):307-8.
1988: Levine M M; Kaper J B; Herrington D; Ketley J; Losonsky G; Tacket C O; Tall B; Cryz S
Safety, immunogenicity, and efficacy of recombinant live oral cholera vaccines, CVD 103 and CVD 103-HgR.
Lancet 1988;2(8609):467-70.
1988: Sunstrum J C; Chrisp C E; Levine M; Glorioso J C
Pathogenicity of glycoprotein C negative mutants of herpes simplex virus type 1 for the mouse central nervous system.
Virus research 1988;11(1):17-32.
1988: Levine M M; Prado V; Robins-Browne R; Lior H; Kaper J B; Moseley S L; Gicquelais K; Nataro J P; Vial P; Tall B
Use of DNA probes and HEp-2 cell adherence assay to detect diarrheagenic Escherichia coli.
The Journal of infectious diseases 1988;158(1):224-8.
1988: Vial P A; Robins-Browne R; Lior H; Prado V; Kaper J B; Nataro J P; Maneval D; Elsayed A; Levine M M
Characterization of enteroadherent-aggregative Escherichia coli, a putative agent of diarrheal disease.
The Journal of infectious diseases 1988;158(1):70-9.
1988: Weber P C; Challberg M D; Nelson N J; Levine M; Glorioso J C
Inversion events in the HSV-1 genome are directly mediated by the viral DNA replication machinery and lack sequence specificity.
Cell 1988;54(3):369-81.
1988: Ferreccio C; Morris J G; Valdivieso C; Prenzel I; Sotomayor V; Drusano G L; Levine M M
Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers.
The Journal of infectious diseases 1988;157(6):1235-9.
1988: Losonsky G A; Rennels M B; Lim Y; Krall G; Kapikian A Z; Levine M M
Systemic and mucosal immune responses to rhesus rotavirus vaccine MMU 18006.
The Pediatric infectious disease journal 1988;7(6):388-93.
1988: Highlander S L; Cai W H; Person S; Levine M; Glorioso J C
Monoclonal antibodies define a domain on herpes simplex virus glycoprotein B involved in virus penetration.
Journal of virology 1988;62(6):1881-8.
1988: Pizarro D; Levine M M; Posada G; Sandi L
Comparison of glucose/electrolyte and glucose/glycine/electrolyte oral rehydration solutions in hospitalized children with diarrhea in Costa Rica.
Journal of pediatric gastroenterology and nutrition 1988;7(3):411-6.
1988: Tacket C O; Losonsky G; Link H; Hoang Y; Guesry P; Hilpert H; Levine M M
Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli.
The New England journal of medicine 1988;318(19):1240-3.
1988: Cryz S J; Fürer E; Levine M M
[Effectiveness of oral, attenuated live Salmonella typhi Ty 21a vaccine in controlled field trials]
Schweizerische medizinische Wochenschrift 1988;118(13):467-70.
1988: Herrington D A; Clyde D F; Murphy J R; Baqar S; Levine M M; do Rosario V; Hollingdale M R
A model for Plasmodium falciparum sporozoite challenge and very early therapy of parasitaemia for efficacy studies of sporozoite vaccines.
Tropical and geographical medicine 1988;40(2):124-7.
1988: Hall R H; Vial P A; Kaper J B; Mekalanos J J; Levine M M
Morphological studies on fimbriae expressed by Vibrio cholerae 01.
Microbial pathogenesis 1988;4(4):257-65.
1988: Kaper J B; Levine M M
Progress towards a vaccine against enterotoxigenic Escherichia coli.
Vaccine 1988;6(2):197-9.
1988: Black R E; Levine M M; Clements M L; Hughes T P; Blaser M J
Experimental Campylobacter jejuni infection in humans.
The Journal of infectious diseases 1988;157(3):472-9.
1988: Levine M M; Vial P
Escherichia coli that cause diarrhea.
Indian journal of pediatrics 1988;55(2):183-90.
1988: Levine M M; Kaper J B; Herrington D; Losonsky G; Morris J G; Clements M L; Black R E; Tall B; Hall R
Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques.
Infection and immunity 1988;56(1):161-7.
1988: Levine M M; Ferreccio C
Typhoid vaccines.
Lancet 1988;1(8578):173.
1988: Homa F L; Glorioso J C; Levine M
A specific 15-bp TATA box promoter element is required for expression of a herpes simplex virus type 1 late gene.
Genes & development 1988;2(1):40-53.
1988: Palella T D; Silverman L J; Schroll C T; Homa F L; Levine M; Kelley W N
Herpes simplex virus-mediated human hypoxanthine-guanine phosphoribosyltransferase gene transfer into neuronal cells.
Molecular and cellular biology 1988;8(1):457-60.
1987: Nash T E; Herrington D A; Losonsky G A; Levine M M
Experimental human infections with Giardia lamblia.
The Journal of infectious diseases 1987;156(6):974-84.
1987: Murphy J R; Baqar S; Muñoz C; Schlesinger L; Ferreccio C; Lindberg A A; Svenson S; Losonsky G; Koster F; Levine M M
Characteristics of humoral and cellular immunity to Salmonella typhi in residents of typhoid-endemic and typhoid-free regions.
The Journal of infectious diseases 1987;156(6):1005-9.
1987: Losonsky G A; Ferreccio C; Kotloff K L; Kaintuck S; Robbins J B; Levine M M
Development and evaluation of an enzyme-linked immunosorbent assay for serum Vi antibodies for detection of chronic Salmonella typhi carriers.
Journal of clinical microbiology 1987;25(12):2266-9.
1987: Tzipori S; Karch H; Wachsmuth K I; Robins-Browne R M; O'Brien A D; Lior H; Cohen M L; Smithers J; Levine M M
Role of a 60-megadalton plasmid and Shiga-like toxins in the pathogenesis of infection caused by enterohemorrhagic Escherichia coli O157:H7 in gnotobiotic piglets.
Infection and immunity 1987;55(12):3117-25.
1987: Highlander S L; Sutherland S L; Gage P J; Johnson D C; Levine M; Glorioso J C
Neutralizing monoclonal antibodies specific for herpes simplex virus glycoprotein D inhibit virus penetration.
Journal of virology 1987;61(11):3356-64.
1987: Shaw R D; Fong K J; Losonsky G A; Levine M M; Maldonado Y; Yolken R; Flores J; Kapikian A Z; Vo P T; Greenberg H B
Epitope-specific immune responses to rotavirus vaccination.
Gastroenterology 1987;93(5):941-50.
1987: Nataro J P; Kaper J B; Robins-Browne R; Prado V; Vial P; Levine M M
Patterns of adherence of diarrheagenic Escherichia coli to HEp-2 cells.
The Pediatric infectious disease journal 1987;6(9):829-31.
1987: Robbins A K; Dorney D J; Wathen M W; Whealy M E; Gold C; Watson R J; Holland L E; Weed S D; Levine M; Glorioso J C
The pseudorabies virus gII gene is closely related to the gB glycoprotein gene of herpes simplex virus.
Journal of virology 1987;61(9):2691-701.
1987: Gotuzzo E; Morris J G; Benavente L; Wood P K; Levine O; Black R E; Levine M M
Association between specific plasmids and relapse in typhoid fever.
Journal of clinical microbiology 1987;25(9):1779-81.
1987: Nash T E; Herrington D A; Levine M M
Usefulness of an enzyme-linked immunosorbent assay for detection of Giardia antigen in feces.
Journal of clinical microbiology 1987;25(7):1169-71.
1987: Levine M M; Xu J G; Kaper J B; Lior H; Prado V; Tall B; Nataro J; Karch H; Wachsmuth K
A DNA probe to identify enterohemorrhagic Escherichia coli of O157:H7 and other serotypes that cause hemorrhagic colitis and hemolytic uremic syndrome.
The Journal of infectious diseases 1987;156(1):175-82.
1987: Karch H; Heesemann J; Laufs R; Kroll H P; Kaper J B; Levine M M
Serological response to type 1-like somatic fimbriae in diarrheal infection due to classical enteropathogenic Escherichia coli.
Microbial pathogenesis 1987;2(6):425-34.
1987: Black R E; Levine M M; Clements M L; Losonsky G; Herrington D; Berman S; Formal S B
Prevention of shigellosis by a Salmonella typhi-Shigella sonnei bivalent vaccine.
The Journal of infectious diseases 1987;155(6):1260-5.
1987: Black R E; Levine M M; Clements M L; Young C R; Svennerholm A M; Holmgren J
Protective efficacy in humans of killed whole-vibrio oral cholera vaccine with and without the B subunit of cholera toxin.
Infection and immunity 1987;55(5):1116-20.
1987: Weber P C; Levine M; Glorioso J C
Rapid identification of nonessential genes of herpes simplex virus type 1 by Tn5 mutagenesis.
Science (New York, N.Y.) 1987;236(4801):576-9.
1987: Levine M M; Ferreccio C; Black R E; Germanier R
Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation.
Lancet 1987;1(8541):1049-52.
1987: Tacket C O; Maneval D R; Levine M M
Purification, morphology, and genetics of a new fimbrial putative colonization factor of enterotoxigenic Escherichia coli O159:H4.
Infection and immunity 1987;55(5):1063-9.
1987: Herrington D A; Tzipori S; Robins-Browne R M; Tall B D; Levine M M
In vitro and in vivo pathogenicity of Plesiomonas shigelloides.
Infection and immunity 1987;55(4):979-85.
1987: Shapira M; Homa F L; Glorioso J C; Levine M
Regulation of the herpes simplex virus type 1 late (gamma 2) glycoprotein C gene: sequences between base pairs -34 to +29 control transient expression and responsiveness to transactivation by the products of the immediate early (alpha) 4 and 0 genes.
Nucleic acids research 1987;15(7):3097-111.
1987: Levine M M; Herrington D; Murphy J R; Morris J G; Losonsky G; Tall B; Lindberg A A; Svenson S; Baqar S; Edwards M F
Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.
The Journal of clinical investigation 1987;79(3):888-902.
1987: Levine M M
Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.
The Journal of infectious diseases 1987;155(3):377-89.
1987: Rennels M B; Losonsky G A; Shindledecker C L; Hughes T P; Kapikian A Z; Levine M M
Immunogenicity and reactogenicity of lowered doses of rhesus rotavirus vaccine strain MMU 18006 in young children.
The Pediatric infectious disease journal 1987;6(3):260-4.
1987: Pizarro D T; Posada G S; Levine M M; Nalin D R; Mohs E V
Comparison of efficacy of oral rehydration fluids administered at 37 degrees C or 23 degrees C.
Journal of tropical pediatrics 1987;33(1):48-51.
1987: Karch H; Heesemann J; Laufs R; O'Brien A D; Tacket C O; Levine M M
A plasmid of enterohemorrhagic Escherichia coli O157:H7 is required for expression of a new fimbrial antigen and for adhesion to epithelial cells.
Infection and immunity 1987;55(2):455-61.
1987: Kikuchi G E; Baker S A; Merajver S D; Coligan J E; Levine M; Glorioso J C; Nairn R
Purification and structural characterization of herpes simplex virus glycoprotein C.
Biochemistry 1987;26(2):424-31.
1987: Holmgren J; Svennerholm A M; Clemens J; Sack D; Black R; Levine M
An oral B subunit-whole cell vaccine against cholera: from concept to successful field trial.
Advances in experimental medicine and biology 1987;216B():1649-60.
1987: Black R E; Levine M M; Clements M L; Hughes T; O'Donnell S
Association between O blood group and occurrence and severity of diarrhoea due to Escherichia coli.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1987;81(1):120-3.
1986: Thompson M R; Jordan R L; Luttrell M A; Brandwein H; Kaper J B; Levine M M; Giannella R A
Blinded, two-laboratory comparative analysis of Escherichia coli heat-stable enterotoxin production by using monoclonal antibody enzyme-linked immunosorbent assay, radioimmunoassay, suckling mouse assay, and gene probes.
Journal of clinical microbiology 1986;24(5):753-8.
1986: Homa F L; Otal T M; Glorioso J C; Levine M
Transcriptional control signals of a herpes simplex virus type 1 late (gamma 2) gene lie within bases -34 to +124 relative to the 5' terminus of the mRNA.
Molecular and cellular biology 1986;6(11):3652-66.
1986: Rennels M B; Losonsky G A; Levine M M; Kapikian A Z
Preliminary evaluation of the efficacy of rhesus rotavirus vaccine strain MMU 18006 in young children.
Pediatric infectious disease 1986;5(5):587-8.
1986: Tacket C O; Ferreccio C; Robbins J B; Tsai C M; Schulz D; Cadoz M; Goudeau A; Levine M M
Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines.
The Journal of infectious diseases 1986;154(2):342-5.
1986: Maher K O; Morris J G; Gotuzzo E; Ferreccio C; Ward L R; Benavente L; Black R E; Rowe B; Levine M M
Molecular techniques in the study of Salmonella typhi in epidemiologic studies in endemic areas: comparison with Vi phage typing.
The American journal of tropical medicine and hygiene 1986;35(4):831-5.
1986: Marlin S D; Highlander S L; Holland T C; Levine M; Glorioso J C
Antigenic variation (mar mutations) in herpes simplex virus glycoprotein B can induce temperature-dependent alterations in gB processing and virus production.
Journal of virology 1986;59(1):142-53.
1986: Edelman R; Levine M M
Summary of an international workshop on typhoid fever.
Reviews of infectious diseases 1986;8(3):329-49.
1986: Levine M M
Antimicrobial therapy for infectious diarrhea.
Reviews of infectious diseases 1986;8 Suppl 2():S207-16.
1986: Homa F L; Purifoy D J; Glorioso J C; Levine M
Molecular basis of the glycoprotein C-negative phenotypes of herpes simplex virus type 1 mutants selected with a virus-neutralizing monoclonal antibody.
Journal of virology 1986;58(2):281-9.
1986: Harris J R; Holmberg S D; Parker R D; Kay D E; Barrett T J; Young C R; Levine M M; Blake P A
Impact of epidemic cholera in a previously uninfected island population: evaluation of a new seroepidemiologic method.
American journal of epidemiology 1986;123(3):424-30.
1986: Sears S D; Ferreccio C; Levine M M
Sensitivity of Moore sewer swabs for isolating Salmonella typhi.
Applied and environmental microbiology 1986;51(2):425-6.
1986: Rennels M B; Levine M M
Classical bacterial diarrhea: perspectives and update--Salmonella, Shigella, Escherichia coli, Aeromonas and Plesiomonas.
Pediatric infectious disease 1986;5(1 Suppl):S91-100.
1986: Levine M M; Losonsky G; Herrington D; Kaper J B; Tacket C; Rennels M B; Morris J G
Pediatric diarrhea: the challenge of prevention.
Pediatric infectious disease 1986;5(1 Suppl):S29-43.
1986: Losonsky G A; Rennels M B; Kapikian A Z; Midthun K; Ferra P J; Fortier D N; Hoffman K M; Baig A; Levine M M
Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants.
Pediatric infectious disease 1986;5(1):25-9.
1986: Germanier R; Levine M M
The live oral typhoid vaccine Ty21a: recent field trial results.
Annali Sclavo. Collana monografica 1986;3(1-2):19-22.
1985: Murray B E; Alvarado T; Kim K H; Vorachit M; Jayanetra P; Levine M M; Prenzel I; Fling M; Elwell L; McCracken G H
Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries.
The Journal of infectious diseases 1985;152(6):1107-13.
1985: Kümel G; Kaerner H C; Levine M; Schröder C H; Glorioso J C
Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity.
Journal of virology 1985;56(3):930-7.
1985: Lanata C F; Kaper J B; Baldini M M; Black R E; Levine M M
Sensitivity and specificity of DNA probes with the stool blot technique for detection of Escherichia coli enterotoxins.
The Journal of infectious diseases 1985;152(5):1087-90.
1985: Nataro J P; Baldini M M; Kaper J B; Black R E; Bravo N; Levine M M
Detection of an adherence factor of enteropathogenic Escherichia coli with a DNA probe.
The Journal of infectious diseases 1985;152(3):560-5.
1985: Levine M M; Nataro J P; Karch H; Baldini M M; Kaper J B; Black R E; Clements M L; O'Brien A D
The diarrheal response of humans to some classic serotypes of enteropathogenic Escherichia coli is dependent on a plasmid encoding an enteroadhesiveness factor.
The Journal of infectious diseases 1985;152(3):550-9.
1985: Levine M M
Escherichia coli infections.
The New England journal of medicine 1985;313(7):445-7.
1985: Schröder C H; DeZazzo J; Knopf K W; Kaerner H C; Levine M; Glorioso J
A herpes simplex virus type 1 mutant with a deletion in the polypeptide-coding sequences of the ICP4 gene.
The Journal of general virology 1985;66 ( Pt 7)():1589-93.
1985: Nataro J P; Scaletsky I C; Kaper J B; Levine M M; Trabulsi L R
Plasmid-mediated factors conferring diffuse and localized adherence of enteropathogenic Escherichia coli.
Infection and immunity 1985;48(2):378-83.
1985: Goldin A L; Sandri-Goldin R M; Glorioso J C; Levine M
Stable induction of a 51K cellular protein in neuronal cells surviving herpes simplex virus type 1 infection.
Virology 1985;142(2):398-405.
1985: Murray B E; Levine M M; Cordano A M; D'Ottone K; Jayanetra P; Kopecko D; Pan-Urae R; Prenzel I
Survey of plasmids in Salmonella typhi from Chile and Thailand.
The Journal of infectious diseases 1985;151(3):551-5.
1985: Levine M M; Young C R; Black R E; Takeda Y; Finkelstein R A
Enzyme-linked immunosorbent assay to measure antibodies to purified heat-labile enterotoxins from human and porcine strains of Escherichia coli and to cholera toxin: application in serodiagnosis and seroepidemiology.
Journal of clinical microbiology 1985;21(2):174-9.
1985: Marlin S D; Holland T C; Levine M; Glorioso J C
Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites.
Journal of virology 1985;53(1):128-36.
1985: Black R E; Cisneros L; Levine M M; Banfi A; Lobos H; Rodriguez H
Case-control study to identify risk factors for paediatric endemic typhoid fever in Santiago, Chile.
Bulletin of the World Health Organization 1985;63(5):899-904.
1984: Kikuchi G E; Coligan J E; Holland T C; Levine M; Glorioso J C; Nairn R
Biochemical characterization of peptides from herpes simplex virus glycoprotein gC: loss of CNBr fragments from the carboxy terminus of truncated, secreted gC molecules.
Journal of virology 1984;52(3):806-15.
1984: Morris J G; Ferreccio C; Garcia J; Lobos H; Black R E; Rodriguez H; Levine M M
Typhoid fever in Santiago, Chile: a study of household contacts of pediatric patients.
The American journal of tropical medicine and hygiene 1984;33(6):1198-202.
1984: Long-Krug S A; Weikel C S; Tiemens K T; Hewlett E L; Levine M M; Guerrant R L
Does enteropathogenic Escherichia coli produce heat-labile enterotoxin, heat-stable enterotoxins a or b, or cholera toxin A subunits?
Infection and immunity 1984;46(2):612-4.
1984: Holland T C; Homa F L; Marlin S D; Levine M; Glorioso J
Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins.
Journal of virology 1984;52(2):566-74.
1984: Svennerholm A M; Levine M M; Holmgren J
Weak serum and intestinal antibody responses to Vibrio cholerae soluble hemagglutinin in cholera patients.
Infection and immunity 1984;45(3):792-4.
1984: Booth I W; Levine M M; Harries J T
Oral rehydration therapy in acute diarrhoea in childhood.
Journal of pediatric gastroenterology and nutrition 1984;3(4):491-9.
1984: Ferreccio C; Levine M M; Manterola A; Rodriguez G; Rivara I; Prenzel I; Black R E; Mancuso T; Bulas D
Benign bacteremia caused by Salmonella typhi and paratyphi in children younger than 2 years.
The Journal of pediatrics 1984;104(6):899-901.
1984: Glorioso J; Schröder C H; Kumel G; Szczesiul M; Levine M
Immunogenicity of herpes simplex virus glycoproteins gC and gB and their role in protective immunity.
Journal of virology 1984;50(3):805-12.
1984: Sears S D; Richardson K; Young C; Parker C D; Levine M M
Evaluation of the human immune response to outer membrane proteins of Vibrio cholerae.
Infection and immunity 1984;44(2):439-44.
1984: Levine M M; Ristaino P; Marley G; Smyth C; Knutton S; Boedeker E; Black R; Young C; Clements M L; Cheney C
Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans.
Infection and immunity 1984;44(2):409-20.
1984: Levine M M; Black R E; Clements M L; Kaper J B
Present status of cholera vaccines.
Biochemical Society transactions 1984;12(2):200-2.
1984: Sears S D; Ferreccio C; Levine M M; Cordano A M; Monreal J; Black R E; D'Ottone K; Rowe B
The use of Moore swabs for isolation of Salmonella typhi from irrigation water in Santiago, Chile.
The Journal of infectious diseases 1984;149(4):640-2.
1984: Kaper J B; Lockman H; Baldini M M; Levine M M
Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates.
Nature 1984;308(5960):655-8.
1984: Sandri-Goldin R M; Goldin A L; Glorioso J; Levine M
Herpes simplex virus thymidine kinase gene is stably maintained and expressed in cells transformed by protoplast fusion.
Somatic cell and molecular genetics 1984;10(2):129-38.
1984: Holland L E; Sandri-Goldin R M; Goldin A L; Glorioso J C; Levine M
Transcriptional and genetic analyses of the herpes simplex virus type 1 genome: coordinates 0.29 to 0.45.
Journal of virology 1984;49(3):947-59.
1984: Levine M M; Black R E; Ferreccio C
Typhoid vaccines: outlook for the future.
Diarrhoea Dialogue 1984;(16):7.
1984: Pizarro D; Posada G; Levine M M
Hypernatremic diarrheal dehydration treated with "slow" (12-hour) oral rehydration therapy: a preliminary report.
The Journal of pediatrics 1984;104(2):316-9.
1984: Levine M M; Black R E; Clements M L; Lanata C; Sears S; Honda T; Young C R; Finkelstein R A
Evaluation in humans of attenuated Vibrio cholerae El Tor Ogawa strain Texas Star-SR as a live oral vaccine.
Infection and immunity 1984;43(2):515-22.
1984: O'Brien A D; Chen M E; Holmes R K; Kaper J; Levine M M
Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.
Lancet 1984;1(8368):77-8.
1984: Levine M M; Pizarro D
Advances in therapy of diarrheal dehydration: oral rehydration.
Advances in pediatrics 1984;31():207-34.
1984: Levine M M; Edelman R
Enteropathogenic Escherichia coli of classic serotypes associated with infant diarrhea: epidemiology and pathogenesis.
Epidemiologic reviews 1984;6():31-51.
1983: Levine M M; Kaper J B; Black R E; Clements M L
New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.
Microbiological reviews 1983;47(4):510-50.
1983: Clements M L; Wisseman C L; Woodward T E; Fiset P; Dumler J S; McNamee W; Black R E; Rooney J; Hughes T P; Levine M M
Reactogenicity, immunogenicity, and efficacy of a chick embryo cell-derived vaccine for Rocky Mountain spotted fever.
The Journal of infectious diseases 1983;148(5):922-30.
1983: Clements M L; Dumler J S; Fiset P; Wisseman C L; Snyder M J; Levine M M
Serodiagnosis of Rocky Mountain spotted fever: comparison of IgM and IgG enzyme-linked immunosorbent assays and indirect fluorescent antibody test.
The Journal of infectious diseases 1983;148(5):876-80.
1983: Sandri-Goldin R M; Goldin A L; Holland L E; Glorioso J C; Levine M
Expression of herpes simplex virus beta and gamma genes integrated in mammalian cells and their induction by an alpha gene product.
Molecular and cellular biology 1983;3(11):2028-44.
1983: Taylor D N; Harris J R; Barrett T J; Hargrett N T; Prentzel I; Valdivieso C; Palomino C; Levine M M; Blake P A
Detection of urinary Vi antigen as a diagnostic test for typhoid fever.
Journal of clinical microbiology 1983;18(4):872-6.
1983: Levine M M; Kaper J B; Lockman H; Black R E; Clements M L; Falkow S
Recombinant DNA risk assessment studies in humans: efficacy of poorly mobilizable plasmids in biologic containment.
The Journal of infectious diseases 1983;148(4):699-709.
1983: Ristaino P A; Levine M M; Young C R
Improved GM1-enzyme-linked immunosorbent assay for detection of Escherichia coli heat-labile enterotoxin.
Journal of clinical microbiology 1983;18(4):808-15.
1983: Moon H W; Whipp S C; Argenzio R A; Levine M M; Giannella R A
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines.
Infection and immunity 1983;41(3):1340-51.
1983: Levine M M; Kaper J B; Lockman H; Black R E; Clements M L; Falkow S
Recombinant DNA risk assessment studies in man: efficacy of poorly mobilizable plasmids in biologic containment.
Recombinant DNA technical bulletin 1983;6(3):89-97.
1983: Pizarro D; Posada G; Villavicencio N; Mohs E; Levine M M
Oral rehydration in hypernatremic and hyponatremic diarrheal dehydration.
American journal of diseases of children (1960) 1983;137(8):730-4.
1983: Lanata C F; Levine M M; Ristori C; Black R E; Jimenez L; Salcedo M; Garcia J; Sotomayor V
Vi serology in detection of chronic Salmonella typhi carriers in an endemic area.
Lancet 1983;2(8347):441-3.
1983: Baldini M M; Kaper J B; Levine M M; Moon H W
Molecular nature of adhesion in enteropathogenic Escherichia coli.
Lancet 1983;2(8343):218.
1983: Kaper J B; Levine M M
Toxins in environmental Vibrio cholerae.
Lancet 1983;2(8343):217-8.
1983: Clements M L; O'Donnell S; Levine M M; Chanock R M; Murphy B R
Dose response of A/Alaska/6/77 (H3N2) cold-adapted reassortant vaccine virus in adult volunteers: role of local antibody in resistance to infection with vaccine virus.
Infection and immunity 1983;40(3):1044-51.
1983: Edelman R; Levine M M
From the National Institute of Allergy and Infectious Diseases. Summary of a workshop on enteropathogenic Escherichia coli.
The Journal of infectious diseases 1983;147(6):1108-18.
1983: Holland T C; Sandri-Goldin R M; Holland L E; Marlin S D; Levine M; Glorioso J C
Physical mapping of the mutation in an antigenic variant of herpes simplex virus type 1 by use of an immunoreactive plaque assay.
Journal of virology 1983;46(2):649-52.
1983: Glorioso J; Szczesiul M S; Marlin S D; Levine M
Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane.
Virology 1983;126(1):1-18.
1983: Levine M M
Vaccines to prevent travelers' diarrhea.
Therapeutische Umschau. Revue thérapeutique 1983;40(3):253-6.
1983: Svennerholm A M; Holmgren J; Black R; Levine M; Merson M
Serologic differentiation between antitoxin responses to infection with Vibrio cholerae and enterotoxin-producing Escherichia coli.
The Journal of infectious diseases 1983;147(3):514-22.
1983: Holland T C; Marlin S D; Levine M; Glorioso J
Antigenic variants of herpes simplex virus selected with glycoprotein-specific monoclonal antibodies.
Journal of virology 1983;45(2):672-82.
1983: Levine M M; Ristaino P; Sack R B; Kaper J B; Orskov F; Orskov I
Colonization factor antigens I and II and type 1 somatic pili in enterotoxigenic Escherichia coli: relation to enterotoxin type.
Infection and immunity 1983;39(2):889-97.
1983: Kapikian A Z; Wyatt R G; Levine M M; Yolken R H; VanKirk D H; Dolin R; Greenberg H B; Chanock R M
Oral administration of human rotavirus to volunteers: induction of illness and correlates of resistance.
The Journal of infectious diseases 1983;147(1):95-106.
1983: Levine M M; Black R E; Clements M L; Young C R; Lanata C; Sears S; Honda T; Finkelstein R
Texas Star-SR: attenuated "Vibrio cholerae" oral vaccine candidate.
Developments in biological standardization 1983;53():59-65.
1983: Clements M L; Levine M M; Ristaino P A; Daya V E; Hughes T P
Exogenous lactobacilli fed to man - their fate and ability to prevent diarrheal disease.
Progress in food & nutrition science 1983;7(3-4):29-37.
1983: Baldini M M; Kaper J B; Levine M M; Candy D C; Moon H W
Plasmid-mediated adhesion in enteropathogenic Escherichia coli.
Journal of pediatric gastroenterology and nutrition 1983;2(3):534-8.
1983: Sandri-Goldin R M; Goldin A L; Levine M; Glorioso J
High-efficiency transfer of DNA into eukaryotic cells by protoplast fusion.
Methods in enzymology 1983;101():402-11.
1983: Wyatt R G; Kapikian A Z; Greenberg H B; Kalica A R; Flores J; Hoshino Y; Chanock R M; Levine M M
Development of vaccines against rotavirus disease.
Progress in food & nutrition science 1983;7(3-4):189-92.
1983: Black R; Levine M M; Young C; Rooney J; Levine S; Clements M L; O'Donnell S; Hugues T; Germanier R
Immunogenicity of Ty21a attenuated "Salmonella typhi" given with sodium bicarbonate or in enteric-coated capsules.
Developments in biological standardization 1983;53():9-14.
1983: Kapikian A Z; Wyatt R G; Levine M M; Black R E; Greenberg H B; Flores J; Kalica A R; Hoshino Y; Chanock R M
Studies in volunteers with human rotaviruses.
Developments in biological standardization 1983;53():209-18.
1983: Levine M M
Travellers' diarrhoea: prospects for successful immunoprophylaxis.
Scandinavian journal of gastroenterology. Supplement 1983;84():121-34.
1982: Levine M M; Black R E; Lanata C
Precise estimation of the numbers of chronic carriers of Salmonella typhi in Santiago, Chile, an endemic area.
The Journal of infectious diseases 1982;146(6):724-6.
1982: Robins-Browne R M; Levine M M; Rowe B; Gabriel E M
Failure to detect conventional enterotoxins in classical enteropathogenic (serotyped) Escherichia coli strains of proven pathogenicity.
Infection and immunity 1982;38(2):798-801.
1982: Hobbins T E; Hughes T P; Rennels M B; Murphy B R; Levine M M
Bronchial reactivity in experimental infections with influenza virus.
The Journal of infectious diseases 1982;146(4):468-71.
1982: Huang C T; Levine M M; Daoud G S; Nalin D R; Nichols B L
Fecal steroids in diarrhea: IV. Cholera.
Lipids 1982;17(9):612-6.
1982: Tolpin M D; Clements M L; Levine M M; Black R E; Saah A J; Anthony W C; Cisneros L; Chanock R M; Murphy B R
Evaluation of a phenotypic revertant of the A/Alaska/77-ts-1A2 reassortant virus in hamsters and in seronegative adult volunteers: further evidence that the temperature-sensitive phenotype is responsible for attenuation of ts-1A2 reassortant viruses.
Infection and immunity 1982;36(2):645-50.
1982: Clements M L; Levine M M; Young C R; Black R E; Lim Y L; Robins-Browne R M; Craig J P
Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae.
The Journal of infectious diseases 1982;145(4):465-73.
1982: Levine M M; Black R E; Clements M L; Cisneros L; Saah A; Nalin D R; Gill D M; Craig J P; Young C R; Ristaino P
The pathogenicity of nonenterotoxigenic Vibrio cholerae serogroup O1 biotype El Tor isolated from sewage water in Brazil.
The Journal of infectious diseases 1982;145(3):296-9.
1982: Black R E; Levine M M; Clements M L; Cisneros L; Daya V
Treatment of experimentally induced enterotoxigenic Escherichia coli diarrhea with trimethoprim, trimethoprim-sulfamethoxazole, or placebo.
Reviews of infectious diseases 1982;4(2):540-5.
1982: Levine M M; Black R E; Brinton C C; Clements M L; Fusco P; Hughes T P; O'Donnell S; Robins-Browne R; Wood S; Young C R
Reactogenicity, immunogenicity and efficacy studies of Escherichia coli type 1 somatic pili parenteral vaccine in man.
Scandinavian journal of infectious diseases. Supplementum 1982;33():83-95.
1981: Kaper J B; Levine M M
Cloned cholera enterotoxin genes in study and prevention of cholera.
Lancet 1981;2(8256):1162-3.
1981: Black R E; Levine M M; Clements M L; Angle P; Robins-Browne R
Proliferation of enteropathogens in oral rehydration solutions prepared with river water from Honduras and Surinam.
The Journal of tropical medicine and hygiene 1981;84(5):195-7.
1981: Levine M M
Oral therapy for diarrhoea: past, present and future.
The Journal of tropical medicine and hygiene 1981;84(5):185-7.
1981: Clements M L; Levine M M; Cleaves F; Hughes T P; Caceres M; Aleman E; Black R E; Rust J
Comparison of simple sugar/salt versus glucose/electrolyte oral rehydration solutions in infant diarrhoea.
The Journal of tropical medicine and hygiene 1981;84(5):189-94.
1981: Levine M M; Young C R; Hughes T P; O'Donnell S; Black R E; Clements M L; Robins-Browne R; Lim Y L
Duration of serum antitoxin response following Vibrio cholerae infection in North Americans: relevance for seroepidemiology.
American journal of epidemiology 1981;114(3):348-54.
1981: Huang C T; Levine M M; Woodward W E; Gopalakrishna G S; Nalin D R; Hornick R B; Nochols B L
Biohydrogenation of cholesterol as an index of bacterial 7 alpha-dehydroxylase activity.
Lipids 1981;16(9):670-6.
1981: Sandri-Goldin R M; Goldin A L; Levine M; Glorioso J C
High-frequency transfer of cloned herpes simplex virus type 1 sequences to mammalian cells by protoplast fusion.
Molecular and cellular biology 1981;1(8):743-52.
1981: Clements M L; Levine M M; Black R E; Robins-Browne R M; Cisneros L A; Drusano G L; Lanata C F; Saah A J
Lactobacillus prophylaxis for diarrhea due to enterotoxigenic Escherichia coli.
Antimicrobial agents and chemotherapy 1981;20(1):104-8.
1981: Levine M M; Black R E; Clements M L; Cisneros L; Nalin D R; Young C R
Duration of infection-derived immunity to cholera.
The Journal of infectious diseases 1981;143(6):818-20.
1981: Murphy B R; Chanock R M; Clements M L; Anthony W C; Sear A J; Cisneros L A; Rennels M B; Miller E H; Black R E; Levine M M; Betts R F; Douglas R G; Maassab H F; Cox N J; Kendal A P
Evaluation of A/Alaska/6/77 (H3N2) cold-adapted recombinant viruses derived from A/Ann Arbor/6/60 cold-adapted donor virus in adult seronegative volunteers.
Infection and immunity 1981;32(2):693-7.
1981: Levine M M; Clements M L; Black R E; Hughes T P; Blum D; Andino R; Corrales G
A practical, reliable method for preparing simple sugar/salt oral rehydration solution.
The Journal of tropical medicine and hygiene 1981;84(2):73-6.
1981: Robins-Browne R M; Levine M M
The fate of ingested lactobacilli in the proximal small intestine.
The American journal of clinical nutrition 1981;34(4):514-9.
1981: Goldin A L; Sandri-Goldin R M; Levine M; Glorioso J C
Cloning of herpes simplex virus type 1 sequences representing the whole genome.
Journal of virology 1981;38(1):50-8.
1981: Sandri-Goldin R M; Levine M; Glorioso J C
Method for induction of mutations in physically defined regions of the herpes simplex virus genome.
Journal of virology 1981;38(1):41-9.
1981: Snyder J D; Allegra D T; Levine M M; Craig J P; Feeley J C; DeWitt W E; Blake P A
Serologic studies of naturally acquired infection with Vibrio cholerae serogroup O1 in the United States.
The Journal of infectious diseases 1981;143(2):182-7.
1981: Robins-Browne R M; Levine M M
Effect of chlorpromazine on intestinal secretion mediated by Escherichia coli heat-stable enterotoxin and 8-Br-cyclic GMP in infant mice.
Gastroenterology 1981;80(2):321-6.
1981: Levine M M
Adhesion of enterotoxigenic Escherichia coli in humans and animals.
Ciba Foundation symposium 1981;80():142-60.
1980: Pizarro D; Posada G; Levine M M; Mohs E
Oral rehydration of infants with acute diarrhoeal dehydration: a practical method.
The Journal of tropical medicine and hygiene 1980;83(6):241-5.
1980: Clements M L; Levine M M; Black R E; Hughes T P; Rust J; Tome F C
Potassium supplements for oral diarrhoea regimens.
Lancet 1980;2(8199):854.
1980: Rennels M B; Levine M M; Daya V; Angle P; Young C
Selective vs. nonselective media and direct plating vs. enrichment technique in isolation of Vibrio cholerae: recommendations for clinical laboratories.
The Journal of infectious diseases 1980;142(3):328-31.
1980: Glorioso J C; Levine M; Holland T C; Szczesiul M S
Mutant analysis of herpes simplex virus-induced cell surface antigens: resistance to complement-mediated immune cytolysis.
Journal of virology 1980;35(3):672-81.
1980: Levine M M; Hughes T P; Black R E; Clements M L; Matheny S; Siegel A; Cleaves F; Gutierrez C; Foote D P; Smith W
Variability of sodium and sucrose levels of simple sugar/salt oral rehydrations solutions prepared under optimal and field conditions.
The Journal of pediatrics 1980;97(2):324-7.
1980: Murphy B R; Rennels M B; Douglas R G; Betts R F; Couch R B; Cate T R; Chanock R M; Kendal A P; Maassab H F; Suwanagool S; Sotman S B; Cisneros L A; Anthony W C; Nalin D R; Levine M M
Evaluation of influenza A/Hong Kong/123/77 (H1N1) ts-1A2 and cold-adapted recombinant viruses in seronegative adult volunteers.
Infection and immunity 1980;29(2):348-55.
1980: Levine M; Goldin A L; Glorioso J C
Persistence of herpes simplex virus genes in cells of neuronal origin.
Journal of virology 1980;35(1):203-10.
1980: Clements M L; Levine M M; Black R E; Hughes T P; Nalin D R; Pizarro D; Hirschhorn N
Oral therapy with glucose electrolyte solution.
Lancet 1980;2(8184):34.
1980: Levine M M; Rennels M B; Daya V; Hughes T P
Hemagglutination and colonization factors in enterotoxigenic and enteropathogenic Escherichia coli that cause diarrhea.
The Journal of infectious diseases 1980;141(6):733-7.
1980: Levine M M; Rennels M B; Cisneros L; Hughes T P; Nalin D R; Young C R
Lack of person-to-person transmission of enterotoxigenic Escherichia coli despite close contact.
American journal of epidemiology 1980;111(3):347-55.
1980: Young C R; Levine M M; Craig J P; Robins-Browne R
Microtiter enzyme-linked immunosorbent assay for immunoglobulin G cholera antitoxin in humans: method and correlation with rabbit skin vascular permeability factor technique.
Infection and immunity 1980;27(2):492-6.
1980: Levine M M
Cholera in Louisiana: old problem, new light.
The New England journal of medicine 1980;302(6):345-7.
1980: Murphy B R; Markoff L J; Chanock R M; Spring S B; Maassab H F; Kendal A P; Cox N J; Levine M M; Douglas R G; Betts R F; Couch R B; Cate T R
Genetic approaches to attenuation of influenza A viruses for man.
Philosophical transactions of the Royal Society of London. Series B, Biological sciences 1980;288(1029):401-15.
1980: Huang C T; Levine M M; Daoud G S; Nalin D R; Nichols B L
Fecal steroids in diarrhea. III. Experimentally-induced travellers' diarrhea.
The American journal of clinical nutrition 1980;33(1):40-4.
1980: Edelman R; Levine M M
Acute diarrheal infections in infants I. Bacterial and viral causes.
Hospital practice 1980;15(1):97-104.
1980: Murphy B R; Chanock R M; Douglas R G; Betts R F; Waterman D H; Holley H P; Hoover D L; Suwanagool S; Nalin D R; Levine M M
Temperature-sensitive mutants of influenza A virus: evaluation of the Alaska/77-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.
Archives of virology 1980;65(2):169-73.
1979: Levine M M; Edelman R
Acute diarrheal infections in infants. I. Epidemiology, Treatment, and prospects for immunoprophylaxis.
Hospital practice 1979;14(12):89-100.
1979: Douglas R G; Markoff L J; Murphy B R; Chanock R M; Betts R F; Hayden F G; Levine M M; Van Blerk G A; Sotman S B; Nalin D R
Live Victoria/75-ts-1[E] influenza A virus vaccines in adult volunteers: role of hemagglutinin immunity in protection against illness and infection caused by influenza A virus.
Infection and immunity 1979;26(1):274-9.
1979: Gunn R A; Kimball A M; Pollard R A; Feeley J C; Feldman R A; Dutta S R; Matthew P P; Mahmood R A; Levine M M
Bottle feeding as a risk factor for cholera in infants.
Lancet 1979;2(8145):730-2.
1979: Nalin D R; Daya V; Reid A; Levine M M; Cisneros L
Adsorption and growth of Vibrio cholerae on chitin.
Infection and immunity 1979;25(2):768-70.
1979: Levine M M; Nalin D R; Rennels M B; Hornick R B; Sotman S; Van Blerk G; Hughes T P; O'Donnell S; Barua D
Genetic susceptibility to cholera.
Annals of human biology 1979;6(4):369-74.
1979: Nalin D R; Levine M M
Hour of onset of cholera and diarrhoea.
Lancet 1979;2(8132):49-50.
1979: Levine M M; Nalin D R; Hoover D L; Bergquist E J; Hornick R B; Young C R
Immunity to enterotoxigenic Escherichia coli.
Infection and immunity 1979;23(3):729-36.
1979: Murphy B R; Holley H P; Berquist E J; Levine M M; Spring S B; Maassab H F; Kendal A P; Chanock R M
Cold-adapted variants of influenza A virus: evaluation in adult seronegative volunteers of A/Scotland/840/74 and A/Victoria/3/75 cold-adapted recombinants derived from the cold-adapted A/Ann Arbor/6/60 strain.
Infection and immunity 1979;23(2):253-9.
1979: Murphy B R; Chanock R M; Levine M M; van Blerk G A; Berquist E J; Douglas R G; Betts R F; Couch R B; Cate T R
Temperature-sensitive mutants of influenza A virus: evaluation of the A/Victoria/75-ts-1A2 temperature-sensitive recombinant virus in seronegative adult volunteers.
Infection and immunity 1979;23(2):249-52.
1979: Levine M M
Shigella and Salmonella diarrhoeal disease.
Tropical doctor 1979;9(1):4-9.
1979: Greenberg H B; Levine M M; Merson M H; Sack R B; Sack D A; Valdesuso J R; Nalin D; Hoover D; Chanock R M; Kapikian A Z
Solid-phase microtiter radioimmunoassay blocking test for detection of antibodies to Escherichia coli heat-labile enterotoxin.
Journal of clinical microbiology 1979;9(1):60-4.
1979: Levine M M; Nalin D R; Craig J P; Hoover D; Bergquist E J; Waterman D; Holley H P; Hornick R B; Pierce N P; Libonati J P
Immunity of cholera in man: relative role of antibacterial versus antitoxic immunity.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1979;73(1):3-9.
1979: Nalin D R; Levine M M; Hornick R B; Bergquist E J; Hoover D; Holley H P; Waterman D; VanBlerk J; Matheny S; Sotman S; Rennels M
The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera.
Transactions of the Royal Society of Tropical Medicine and Hygiene 1979;73(1):10-4.
1979: Pizarro D; Posada G; Mohs E; Levine M M; Nalin D R
Evaluation of oral therapy for infant diarrhoea in an emergency room setting: the acute episode as an opportunity for instructing mothers in home treatment.
Bulletin of the World Health Organization 1979;57(6):983-6.
1979: Nalin D R; Levine M M; Mata L; de Céspedes C; Vargas W; Lizano C; Loria A R; Simhon A; Mohs E
Oral rehydration and maintenance of children with rotavirus and bacterial diarrhoeas.
Bulletin of the World Health Organization 1979;57(3):453-9.
1978: Nalin D R; Levine M M; Young C R; Bergquist E J; McLaughlin J C
Increased Escherichia coli enterotoxin detection after concentrating culture supernatants: possible new enterotoxin detectable in dogs but not in infant mice.
Journal of clinical microbiology 1978;8(6):700-3.
1978: Nalin D R; Levine M M; Rhead J; Bergquist E; Rennels M; Hughes T; O'Donnel S; Hornick R B
Cannabis, hypochlorhydria, and cholera.
Lancet 1978;2(8095):859-62.
1978: Nalin D R; Levine R J; Levine M M; Hoover D; Bergquist E; McLaughlin J; Libonati J; Alam J; Hornick R B
Cholera, non-vibrio cholera, and stomach acid.
Lancet 1978;2(8095):856-9.
1978: Levine M M; Rennels M B
E. coli colonisation factor antigen in diarrhoea.
Lancet 1978;2(8088):534.
1978: Adler R; Glorioso J C; Cossman J; Levine M
Possible role of Fc receptors on cells infected and transformed by herpesvirus: escape from immune cytolysis.
Infection and immunity 1978;21(2):442-7.
1978: Nalin D R; Levine M M; Mata L; de Cespedes C; Vargas W; Lizano C; Loria A R; Simhon A; Mohs E
Comparison of sucrose with glucose in oral therapy of infant diarrhoea.
Lancet 1978;2(8084):277-9.
1978: Levine M M; Grados O; Gilman R H; Woodward W E; Solis-Plaza R; Waldman W
Diagnostic value of the Widal test in areas endemic for typhoid fever.
The American journal of tropical medicine and hygiene 1978;27(4):795-800.
1978: Levine M M; Hughes T P; Young C R; O'Donnell S; Craig J P; Holley H P; Bergquist E J
Antigenicity of purified glutaraldehyde-treated cholera toxoid administered orally.
Infection and immunity 1978;21(1):158-62.
1978: Murphy B R; Markoff L J; Hosier N T; Rusten H M; Chanock R M; Kendal A P; Douglas R G; Betts R F; Cate T R; Couch R B; Levine M M; Waterman D H; Holley H P
Temperature-sensitive mutants of influenza A virus: evaluation of A/Victoria/3/75-ts-1[E] recombinant viruses in volunteers.
Infection and immunity 1978;20(3):671-7.
1978: Levine M M; Bergquist E J; Nalin D R; Waterman D H; Hornick R B; Young C R; Sotman S
Escherichia coli strains that cause diarrhoea but do not produce heat-labile or heat-stable enterotoxins and are non-invasive.
Lancet 1978;1(8074):1119-22.
1978: Wald E R; Levine M M
Haemophilus influenzae type b pneumonia.
Archives of disease in childhood 1978;53(4):316-8.
1978: Adler R; Glorioso J C; Levine M
Infection by herpes simplex virus and cells of nervous system origin: characterization of a non-permissive interaction.
The Journal of general virology 1978;39(1):9-20.
1978: Weaver S; Levine M
Replication in situ and DNA encapsulation following induction of an excision-defective lysogen of Salmonella bacteriophage P22.
Journal of molecular biology 1978;118(3):389-411.
1977: Gilman R H; Hornick R B; Woodard W E; DuPont H L; Snyder M J; Levine M M; Libonati J P
Evaluation of a UDP-glucose-4-epimeraseless mutant of Salmonella typhi as a liver oral vaccine.
The Journal of infectious diseases 1977;136(6):717-23.
1977: Levine M M; Hughes T P; Simon P; O'Donnell S; Grauel S; Levine S G
Monovalent inactivated A/New Jersey/8/76 (Hsw1N1) vaccine in healthy children aged three to five years.
The Journal of infectious diseases 1977;136 Suppl():S571-4.
1977: Caplan E S; Hughes T P; O'Donnel S; Levine M M; Hornick R B
Reactogenicity and immunogenicity of parenteral monovalent influenza A/Victoria/3/75 (H3N2) virus vaccine in healthy adults.
The Journal of infectious diseases 1977;136 Suppl():S484-90.
1977: Levine M M; Woodward W E; Formal S B; Gemski P; DuPont H L; Hornick R B; Snyder M J
Studies with a new generation of oral attenuated shigella vaccine: Escherichia coli bearing surface antigens of Shigella flexneri.
The Journal of infectious diseases 1977;136(4):577-82.
1977: Richman D D; Murphy B R; Belshe R B; Rusten H M; Chanock R M; Blacklow N R; Parrino T A; Rose F B; Levine M M; Caplan E
Temperature-sensitive mutants of influenza A virus. XIV. Production and evaluation of influenza A/Georgia/74-ts-1[E] recombinant viruses in human adults.
The Journal of infectious diseases 1977;136(2):256-62.
1977: Levine M M; Caplan E S; Waterman D; Cash R A; Hornick R B; Snyder M J
Diarrhea caused by Escherichia coli that produce only heat-stable enterotoxin.
Infection and immunity 1977;17(1):78-82.
1977: Weaver S; Levine M
Recombinational circularization of Salmonella phage P22 DNA.
Virology 1977;76(1):29-38.
1977: Weaver S; Levine M
The timing of erf-mediated recombination in replication, lysogenization, and the formation of recombinant progeny by Salmonella phage P22.
Virology 1977;76(1):19-28.
1976: Richman D D; Murphy B R; Chanock R M; Gwaltney J M; Douglas R G; Betts R F; Blacklow N R; Rose F B; Parrino T A; Levine M M; Caplan E S
Temperature-sensitive mutants of influenza A virus. XII. Safety, antigenicity, transmissibility, and efficacy of influenza A/Udorn/72-ts-1[E] recombinant viruses in human adults.
The Journal of infectious diseases 1976;134(6):585-94.
1976: Miller R M; Garbus J; Schwartz A R; DuPont H L; Levine M M; Clyde D F; Hornick R B
A modified leukocyte nitroblue tetrazolium test in acute bacterial infection.
American journal of clinical pathology 1976;66(5):905-10.
1976: Levine M M; Gangarosa E J; Barrow W B; Weiss C F
Shigellosis in custodial institutions. V. Effect of intervention with streptomycin-dependent Shigella sonnei vaccine in an institution with endemic disease.
American journal of epidemiology 1976;104(1):88-92.
1976: Levine M M; DuPont H L; Hornick R B; Snyder M J; Woodward W; Gilman R H; Libonati J P
Attenuated, streptomycin-dependent Salmonella typhi oral vaccine: potential deleterious effects of lyophilization.
The Journal of infectious diseases 1976;133(4):424-9.
1976: Wald E R; Levine M M
Frequency of detection of Hemophilus influenzae type b capsular polysaccharide in infants and children with pneumonia.
Pediatrics 1976;57(2):266-8.
1976: Keusch G T; Jacewicz M; Levine M M; Hornick R B; Kochwa S
Pathogenesis of shigella diarrhea. Serum anticytotoxin antibody response produced by toxigenic and nontoxigenic Shigella dysenteriae 1.
The Journal of clinical investigation 1976;57(1):194-202.
1976: Hornick R B; DuPont H L; Levine M M; Gilman R H; Woodward W E; Snyder M J; Woodward T E
Efficacy of a live oral typhoid vaccine in human volunteers.
Developments in biological standardization 1976;33():89-92.
1975: Hoffman B; Levine M
Bacteriophage P22 virion protein which performs an essential early function. II. Characterization of the gene 16 function.
Journal of virology 1975;16(6):1547-59.
1975: Hoffman B; Levine M
Bacteriophage P22 virion protein which performs an essential early function. I. Analysis of 16-ts mutants.
Journal of virology 1975;16(6):1536-46.
1975: Gilman R H; Terminel M; Levine M M; Hernandez-Mendosa P; Calderone E; Vasquez V; Martinez E; Snyder M J; Hornick R B
Comparison of trimethoprim-sulfamethoxazole and amoxicillin in therapy of chloramphenicol-resistant and chloramphenicol-sensitive typhoid fever.
The Journal of infectious diseases 1975;132(6):630-6.
1975: Levine M M; Hornick R B
Lactulose therapy in Shigella carrier state and acute dysentery.
Antimicrobial agents and chemotherapy 1975;8(5):581-4.
1975: Gilman R H; Terminel M; Levine M M; Hernandez-Mendoza P; Hornick R B
Relative efficacy of blood, urine, rectal swab, bone-marrow, and rose-spot cultures for recovery of Salmonella typhi in typhoid fever.
Lancet 1975;1(7918):1211-3.
1974: Levine M M; Togo Y; Wald E R
Practicability of influenza surveillance by virus culture of children.
American journal of epidemiology 1974;100(4):272-6.
1974: Levine M M
Live-virus vaccines in pregnancy. Risks and recommendations.
Lancet 1974;2(7871):34-8.
1974: Levine M M; Gangarosa E J; Werner M; Morris G K
Shigellosis in custodial institutions. 3. Prospective clinical and bacteriologic surveillance of children vaccinated with oral attenuated shigella vaccines.
The Journal of pediatrics 1974;84(6):803-6.
1974: Levine M M; Rice P A; Gangarosa E J; Morris G K; Snyder M J; Formal S B; Wells J G; Gemski P; Hammond J
An outbreak of Sonne shigellosis in a population receiving oral attenuated shigella vaccines.
American journal of epidemiology 1974;99(1):30-6.
1973: Wald E R; Levine M M; Togo Y
Concomitant varicella and staphylococcal scalded skin syndrome.
The Journal of pediatrics 1973;83(6):1017-9.
1973: Wertz G W; Levine M
RNA synthesis by vesicular stomatitis virus and a small plaque mutant: effects of cycloheximide.
Journal of virology 1973;12(2):253-64.
1973: Levine M M; DuPont H L; Khodabandelou M; Hornick R B
Long-term Shigella-carrier state.
The New England journal of medicine 1973;288(22):1169-71.
1973: Levine M M; DuPont H L; Formal S B; Hornick R B; Takeuchi A; Gangarosa E J; Snyder M J; Libonati J P
Pathogenesis of Shigella dysenteriae 1 (Shiga) dysentery.
The Journal of infectious diseases 1973;127(3):261-70.
1973: Bronson M J; Levine M
A component mutation of virB virulence affects lysogenization by phage P22.
Virology 1973;51(2):504-5.
1972: Israel V; Rosen H; Levine M
Binding of bacteriophage P22 tail parts to cells.
Journal of virology 1972;10(6):1152-8.
1972: Levine M M; Dupont H L; Gangarosa E J; Hornick R B; Snyder M J; Libonati J P; Glaser K; Formal S B
Shigellosis in custodial institutions. II. Clinical, immunologic and bacteriologic response of institutionalized children to oral attenuated shigella vaccines.
American journal of epidemiology 1972;96(1):40-9.
1972: Israel V; Woodworth-Gutai M; Levine M
Inhibitory effect of bacteriophage P22 infection on host cell deoxyribonuclease activity.
Journal of virology 1972;9(5):752-7.
1972: Woodworth-Gutai M; Israel V; Levine M
New deoxyribonuclease activity after bacteriophage P22 infection.
Journal of virology 1972;9(5):746-51.
1972: Bronson M J; Levine M
Virulent mutants of phage P22. II. Physiological analysis of P22 virB-3 and its component mutations.
Virology 1972;47(3):644-55.
1971: Clyde D F; Miller R M; Schwartz A R; Levine M M
Treatment of falciparum malaria with sulfalene and trimethoprim.
The American journal of tropical medicine and hygiene 1971;20(6):804-10.
1971: Darlington O F; Levine M
Superinfection exclusion by P22 prophage and the replication complex.
Journal of virology 1971;8(3):347-8.
1971: Bronson M J; Levine M
Virulent mutants of bacteriophage p22.I. Isolation and genetic analysis.
Journal of virology 1971;7(5):559-68.
1970: Levine M; Chakravorty M; Bronson M J
Control of the replication complex of bacteriophage P22.
Journal of virology 1970;6(4):400-5.
1970: Levine M M; DuPont H L; Formal S B; Gangarosa E J
Epidemic Shiga dysentery in Central America.
Lancet 1970;2(7673):607-8.
1970: Chakravorty M; Levine M
Absence of immunity to superinfection in spheroplasts of a lysogen.
Journal of virology 1970;5(2):264-5.
1967: Smith H O; Levine M
A phage P22 gene controlling integration of prophage.
Virology 1967;31(2):207-16.
1966: Cohen L W; Levine M
Detection of proteins synthesized during the establishment of lysogeny with phage P22.
Virology 1966;28(2):208-13.
1965: Smith H O; Levine M
Gene order in prophage P22.
Virology 1965;27(2):229-31.
1965: SMITH H O; LEVINE M
THE SYNTHESIS OF PHAGE AND HOST DNA IN THE ESTABLISHMENT OF LYSOGENY.
Virology 1965;25():585-90.
1963: LEVINE M; BORTHWICK M
THE ACTION OF STREPTONIGRIN ON BACTERIAL DNA METABOLISM AND ON INDUCTION OF PHAGE PRODUCTION IN LYSOGENIC BACTERIA.
Virology 1963;21():568-74.
1961: LEVINE M; CURTISS R
Genetic fine structure of the C region and the linkage map of phage P22.
Genetics 1961;46():1573-80.
1961: LEVINE M
Effect of mitomycin C on interactions between temperate phages and bacteria.
Virology 1961;13():493-9.
1960: LEVINE M; CURTISS R
An effect of chloramphenicol on genetic recombination and selection in phage.
Virology 1960;10():370-1.
1958: LEVINE M; CURTISS R
A genetic test for side-chains in a phage chromosome.
Nature 1958;182(4628):126-7.
1957: LEVINE M
Mutations in the temperate phage P22 and lysogeny in Salmonella.
Virology 1957;3(1):22-41.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Myron Levine

Research Profile (preview)

Chemicals & Drugs

Living Beings

Disorders

Procedures

Geographic Areas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Myron Levine (preview)

All Publications